CN118267386A - Kv3通道的调节剂用于治疗疼痛 - Google Patents

Info

Publication number

CN118267386A

CN118267386A CN202410102663.8A CN202410102663A CN118267386A CN 118267386 A CN118267386 A CN 118267386A CN 202410102663 A CN202410102663 A CN 202410102663A CN 118267386 A CN118267386 A CN 118267386A

Authority

CN

China

Prior art keywords

methyl

oxy

pain

compound

ethyl

Prior art date

2015-12-10

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 208000002193 Pain Diseases 0.000 title claims abstract description 105
• 230000036407 pain Effects 0.000 title claims abstract description 84
• 238000011282 treatment Methods 0.000 title claims abstract description 37
• 230000002265 prevention Effects 0.000 claims abstract description 17
• 238000000034 method Methods 0.000 claims description 39
• 239000000203 mixture Substances 0.000 claims description 34
• 239000003814 drug Substances 0.000 claims description 29
• 208000000094 Chronic Pain Diseases 0.000 claims description 15
• 239000008194 pharmaceutical composition Substances 0.000 claims description 11
• 208000001294 Nociceptive Pain Diseases 0.000 claims description 6
• 238000004519 manufacturing process Methods 0.000 claims description 6
• 229940124597 therapeutic agent Drugs 0.000 claims description 6
• 208000005298 acute pain Diseases 0.000 claims description 4
• 239000000546 pharmaceutical excipient Substances 0.000 claims 1
• 150000001875 compounds Chemical class 0.000 abstract description 235
• 150000003839 salts Chemical class 0.000 abstract description 51
• 239000012453 solvate Substances 0.000 abstract description 39
• 108091006146 Channels Proteins 0.000 description 117
• 125000000217 alkyl group Chemical group 0.000 description 116
• 210000002683 foot Anatomy 0.000 description 110
• 230000000694 effects Effects 0.000 description 77
• 210000004027 cell Anatomy 0.000 description 71
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 59
• 229910052739 hydrogen Inorganic materials 0.000 description 52
• 208000004296 neuralgia Diseases 0.000 description 47
• 208000021722 neuropathic pain Diseases 0.000 description 47
• 229910052799 carbon Inorganic materials 0.000 description 44
• 230000003447 ipsilateral effect Effects 0.000 description 38
• 239000000243 solution Substances 0.000 description 31
• 206010065390 Inflammatory pain Diseases 0.000 description 29
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 29
• 238000012360 testing method Methods 0.000 description 28
• 241000282414 Homo sapiens Species 0.000 description 25
• 229910052731 fluorine Inorganic materials 0.000 description 25
• 125000004430 oxygen atom Chemical group O* 0.000 description 25
• 229910052736 halogen Inorganic materials 0.000 description 24
• 150000002367 halogens Chemical class 0.000 description 24
• 229940125904 compound 1 Drugs 0.000 description 22
• 238000003556 assay Methods 0.000 description 21
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 21
• NXFFJDQHYLNEJK-UHFFFAOYSA-N 2-[4-[(4-chlorophenyl)methyl]-7-fluoro-5-methylsulfonyl-2,3-dihydro-1h-cyclopenta[b]indol-3-yl]acetic acid Chemical compound C1=2C(S(=O)(=O)C)=CC(F)=CC=2C=2CCC(CC(O)=O)C=2N1CC1=CC=C(Cl)C=C1 NXFFJDQHYLNEJK-UHFFFAOYSA-N 0.000 description 20
• 125000003545 alkoxy group Chemical group 0.000 description 20
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 20
• 241000700159 Rattus Species 0.000 description 19
• 229940125782 compound 2 Drugs 0.000 description 19
• 125000000623 heterocyclic group Chemical group 0.000 description 19
• 230000001404 mediated effect Effects 0.000 description 19
• 230000000638 stimulation Effects 0.000 description 19
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 18
• 210000000078 claw Anatomy 0.000 description 18
• 230000035945 sensitivity Effects 0.000 description 18
• 210000002569 neuron Anatomy 0.000 description 17
• 230000035601 cold sensitivity Effects 0.000 description 15
• 229940126214 compound 3 Drugs 0.000 description 14
• 229910052757 nitrogen Inorganic materials 0.000 description 14
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
• 229940079593 drug Drugs 0.000 description 13
• 125000005843 halogen group Chemical group 0.000 description 13
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 13
• 230000009467 reduction Effects 0.000 description 13
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 13
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 13
• -1 e.g. Inorganic materials 0.000 description 12
• 238000002474 experimental method Methods 0.000 description 12
• 230000014509 gene expression Effects 0.000 description 12
• 239000007924 injection Substances 0.000 description 12
• 238000002347 injection Methods 0.000 description 12
• 229920000728 polyester Polymers 0.000 description 12
• 230000002829 reductive effect Effects 0.000 description 12
• 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 10
• BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 10
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
• 201000010099 disease Diseases 0.000 description 10
• 125000006413 ring segment Chemical group 0.000 description 10
• 229920006395 saturated elastomer Polymers 0.000 description 10
• 208000004454 Hyperalgesia Diseases 0.000 description 9
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
• 230000008859 change Effects 0.000 description 9
• 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 9
• 125000001153 fluoro group Chemical group F* 0.000 description 9
• 230000028161 membrane depolarization Effects 0.000 description 9
• 239000013641 positive control Substances 0.000 description 9
• JDXXXJZVGJSURS-UHFFFAOYSA-N 1-cyclohexyl-1-[(7,8-dimethyl-2-oxo-1h-quinolin-3-yl)methyl]-3-phenylurea Chemical compound O=C1NC2=C(C)C(C)=CC=C2C=C1CN(C(=O)NC=1C=CC=CC=1)C1CCCCC1 JDXXXJZVGJSURS-UHFFFAOYSA-N 0.000 description 8
• 230000003542 behavioural effect Effects 0.000 description 8
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 8
• 230000003834 intracellular effect Effects 0.000 description 8
• 229960001848 lamotrigine Drugs 0.000 description 8
• PYZRQGJRPPTADH-UHFFFAOYSA-N lamotrigine Chemical compound NC1=NC(N)=NN=C1C1=CC=CC(Cl)=C1Cl PYZRQGJRPPTADH-UHFFFAOYSA-N 0.000 description 8
• 210000004962 mammalian cell Anatomy 0.000 description 8
• 210000000278 spinal cord Anatomy 0.000 description 8
• JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical compound C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 description 7
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 7
• 239000007995 HEPES buffer Substances 0.000 description 7
• 241001465754 Metazoa Species 0.000 description 7
• 230000004913 activation Effects 0.000 description 7
• 230000009849 deactivation Effects 0.000 description 7
• 229960001259 diclofenac Drugs 0.000 description 7
• DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 7
• 125000005842 heteroatom Chemical group 0.000 description 7
• 238000005259 measurement Methods 0.000 description 7
• 210000005036 nerve Anatomy 0.000 description 7
• 210000003497 sciatic nerve Anatomy 0.000 description 7
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
• TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
• 102000004257 Potassium Channel Human genes 0.000 description 6
• 208000027418 Wounds and injury Diseases 0.000 description 6
• 230000006399 behavior Effects 0.000 description 6
• HUCVOHYBFXVBRW-UHFFFAOYSA-M caesium hydroxide Chemical compound [OH-].[Cs+] HUCVOHYBFXVBRW-UHFFFAOYSA-M 0.000 description 6
• 125000001309 chloro group Chemical group Cl* 0.000 description 6
• 125000004093 cyano group Chemical group *C#N 0.000 description 6
• 239000011737 fluorine Substances 0.000 description 6
• 208000014674 injury Diseases 0.000 description 6
• 210000001153 interneuron Anatomy 0.000 description 6
• 230000036961 partial effect Effects 0.000 description 6
• 108020001213 potassium channel Proteins 0.000 description 6
• 238000002360 preparation method Methods 0.000 description 6
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 6
• 239000000725 suspension Substances 0.000 description 6
• CBXCPBUEXACCNR-UHFFFAOYSA-N tetraethylammonium Chemical compound CC[N+](CC)(CC)CC CBXCPBUEXACCNR-UHFFFAOYSA-N 0.000 description 6
• 239000003981 vehicle Substances 0.000 description 6
• YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 5
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
• 206010020751 Hypersensitivity Diseases 0.000 description 5
• 239000002253 acid Substances 0.000 description 5
• 230000009471 action Effects 0.000 description 5
• 230000036982 action potential Effects 0.000 description 5
• 239000004480 active ingredient Substances 0.000 description 5
• 208000026935 allergic disease Diseases 0.000 description 5
• 238000004458 analytical method Methods 0.000 description 5
• 210000004556 brain Anatomy 0.000 description 5
• 210000003169 central nervous system Anatomy 0.000 description 5
• 230000006378 damage Effects 0.000 description 5
• 231100000673 dose–response relationship Toxicity 0.000 description 5
• 230000006870 function Effects 0.000 description 5
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 5
• 230000001537 neural effect Effects 0.000 description 5
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
• 230000004044 response Effects 0.000 description 5
• 239000011780 sodium chloride Substances 0.000 description 5
• 239000011550 stock solution Substances 0.000 description 5
• 208000024891 symptom Diseases 0.000 description 5
• 239000003826 tablet Substances 0.000 description 5
• SKXPEZRPXUSJHY-IKJXHCRLSA-N (5r)-5-ethyl-3-[2-[[3-methyl-3-(trifluoromethyl)-1h-2-benzofuran-5-yl]oxy]pyrimidin-5-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(COC2(C)C(F)(F)F)C2=C1 SKXPEZRPXUSJHY-IKJXHCRLSA-N 0.000 description 4
• XYISZEPLGKRZAR-NYRJJRHWSA-N (5r)-5-ethyl-3-[6-[[3-methyl-3-(trifluoromethyl)-1h-2-benzofuran-5-yl]oxy]pyridin-3-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COC2(C)C(F)(F)F)C2=C1 XYISZEPLGKRZAR-NYRJJRHWSA-N 0.000 description 4
• BLJABDKRDIIYLJ-UHFFFAOYSA-N 3-[6-[(3-tert-butyl-1,3-dihydro-2-benzofuran-5-yl)oxy]pyridin-3-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound C1=C2C(C(C)(C)C)OCC2=CC=C1OC(N=C1)=CC=C1N1C(=O)NC(C)(C)C1=O BLJABDKRDIIYLJ-UHFFFAOYSA-N 0.000 description 4
• 125000002373 5 membered heterocyclic group Chemical group 0.000 description 4
• PFWPHOLELOXFFV-UHFFFAOYSA-N 5,5-dimethyl-3-[2-[[3-methyl-3-(trifluoromethyl)-1h-2-benzofuran-5-yl]oxy]pyrimidin-5-yl]imidazolidine-2,4-dione Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(COC2(C)C(F)(F)F)C2=C1 PFWPHOLELOXFFV-UHFFFAOYSA-N 0.000 description 4
• NKMHTNGMJVHRTM-UHFFFAOYSA-N 5,5-dimethyl-3-[6-[[3-methyl-3-(trifluoromethyl)-1h-2-benzofuran-5-yl]oxy]pyridin-3-yl]imidazolidine-2,4-dione Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COC2(C)C(F)(F)F)C2=C1 NKMHTNGMJVHRTM-UHFFFAOYSA-N 0.000 description 4
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
• YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
• UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 description 4
• 208000035154 Hyperesthesia Diseases 0.000 description 4
• 206010028391 Musculoskeletal Pain Diseases 0.000 description 4
• 102000003923 Protein Kinase C Human genes 0.000 description 4
• 108090000315 Protein Kinase C Proteins 0.000 description 4
• 125000004429 atom Chemical group 0.000 description 4
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
• 239000011575 calcium Substances 0.000 description 4
• 229910052791 calcium Inorganic materials 0.000 description 4
• 239000002775 capsule Substances 0.000 description 4
• 239000006285 cell suspension Substances 0.000 description 4
• 239000000460 chlorine Substances 0.000 description 4
• 230000007423 decrease Effects 0.000 description 4
• 238000007429 general method Methods 0.000 description 4
• BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 4
• WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 4
• 230000009610 hypersensitivity Effects 0.000 description 4
• 230000002045 lasting effect Effects 0.000 description 4
• 230000002981 neuropathic effect Effects 0.000 description 4
• IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
• 239000002904 solvent Substances 0.000 description 4
• 210000001519 tissue Anatomy 0.000 description 4
• 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 4
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
• 125000004070 6 membered heterocyclic group Chemical group 0.000 description 3
• 102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 3
• 108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 3
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
• GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 3
• 102000004310 Ion Channels Human genes 0.000 description 3
• 108090000862 Ion Channels Proteins 0.000 description 3
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
• JUUFBMODXQKSTD-UHFFFAOYSA-N N-[2-amino-6-[(4-fluorophenyl)methylamino]-3-pyridinyl]carbamic acid ethyl ester Chemical compound N1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CC=C(F)C=C1 JUUFBMODXQKSTD-UHFFFAOYSA-N 0.000 description 3
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
• 230000001154 acute effect Effects 0.000 description 3
• 239000000443 aerosol Substances 0.000 description 3
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
• 229910052801 chlorine Inorganic materials 0.000 description 3
• 238000007405 data analysis Methods 0.000 description 3
• 208000035475 disorder Diseases 0.000 description 3
• 239000002552 dosage form Substances 0.000 description 3
• 239000003937 drug carrier Substances 0.000 description 3
• 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 3
• DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 3
• PCOBBVZJEWWZFR-UHFFFAOYSA-N ezogabine Chemical compound C1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CC=C(F)C=C1 PCOBBVZJEWWZFR-UHFFFAOYSA-N 0.000 description 3
• 229960003667 flupirtine Drugs 0.000 description 3
• 238000009472 formulation Methods 0.000 description 3
• 239000008103 glucose Substances 0.000 description 3
• 210000000548 hind-foot Anatomy 0.000 description 3
• GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 3
• 229940097277 hygromycin b Drugs 0.000 description 3
• 230000002779 inactivation Effects 0.000 description 3
• 230000002757 inflammatory effect Effects 0.000 description 3
• 230000005764 inhibitory process Effects 0.000 description 3
• CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 3
• 239000007788 liquid Substances 0.000 description 3
• 239000007937 lozenge Substances 0.000 description 3
• 239000011777 magnesium Substances 0.000 description 3
• 229910052749 magnesium Inorganic materials 0.000 description 3
• 229910001629 magnesium chloride Inorganic materials 0.000 description 3
• 238000007726 management method Methods 0.000 description 3
• BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 3
• 239000003921 oil Substances 0.000 description 3
• 235000019198 oils Nutrition 0.000 description 3
• 210000000287 oocyte Anatomy 0.000 description 3
• 208000035824 paresthesia Diseases 0.000 description 3
• 239000008188 pellet Substances 0.000 description 3
• 230000002093 peripheral effect Effects 0.000 description 3
• 230000000144 pharmacologic effect Effects 0.000 description 3
• 239000011591 potassium Substances 0.000 description 3
• 229910052700 potassium Inorganic materials 0.000 description 3
• 239000000843 powder Substances 0.000 description 3
• 238000011552 rat model Methods 0.000 description 3
• 229960003312 retigabine Drugs 0.000 description 3
• 230000001953 sensory effect Effects 0.000 description 3
• 238000007619 statistical method Methods 0.000 description 3
• 238000010361 transduction Methods 0.000 description 3
• 230000026683 transduction Effects 0.000 description 3
• MCSCOJJHSDROQX-QGZVFWFLSA-N (5r)-3-[2-[(2,2-difluoro-7-methyl-1,3-benzodioxol-4-yl)oxy]pyrimidin-5-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(C)C2=C1OC(F)(F)O2 MCSCOJJHSDROQX-QGZVFWFLSA-N 0.000 description 2
• PXGUUSBQQRYVGW-FBLFFUNLSA-N (5r)-3-[2-[(3-cyclopropyl-1,3-dihydro-2-benzofuran-5-yl)oxy]pyrimidin-5-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(COC2C3CC3)C2=C1 PXGUUSBQQRYVGW-FBLFFUNLSA-N 0.000 description 2
• RFDFIGVUTNWOAX-IVAFLUGOSA-N (5r)-3-[2-[(3-tert-butyl-1,3-dihydro-2-benzofuran-5-yl)oxy]pyrimidin-5-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(COC2C(C)(C)C)C2=C1 RFDFIGVUTNWOAX-IVAFLUGOSA-N 0.000 description 2
• UTNPAJXEQYBRPF-JOCHJYFZSA-N (5r)-3-[4-[(3,3-dimethyl-1h-2-benzofuran-5-yl)oxy]phenyl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=C1)=CC=C1OC1=CC=C(COC2(C)C)C2=C1 UTNPAJXEQYBRPF-JOCHJYFZSA-N 0.000 description 2
• SHSPZEJVBTZRAQ-OAQYLSRUSA-N (5r)-3-[6-[(3,3-dimethyl-1h-2-benzofuran-5-yl)oxy]pyridin-3-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COC2(C)C)C2=C1 SHSPZEJVBTZRAQ-OAQYLSRUSA-N 0.000 description 2
• OWZHSHKAPQCKHB-MRXNPFEDSA-N (5r)-3-[6-[(3,3-dimethyl-1h-2-benzofuran-5-yl)oxy]pyridin-3-yl]-5-ethylimidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COC2(C)C)C2=C1 OWZHSHKAPQCKHB-MRXNPFEDSA-N 0.000 description 2
• DLJGXIMVMXQVOL-AVKWCDSFSA-N (5r)-3-[6-[(3-cyclopropyl-1,3-dihydro-2-benzofuran-5-yl)oxy]pyridin-3-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COC2C3CC3)C2=C1 DLJGXIMVMXQVOL-AVKWCDSFSA-N 0.000 description 2
• HEDYZGNKUJMEMM-LEQGEALCSA-N (5r)-3-[6-[(3-tert-butyl-1,3-dihydro-2-benzofuran-5-yl)oxy]pyridin-3-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COC2C(C)(C)C)C2=C1 HEDYZGNKUJMEMM-LEQGEALCSA-N 0.000 description 2
• LSOZZXGDMKCFRV-MRXNPFEDSA-N (5r)-5-ethyl-3-(2-spiro[1h-2-benzofuran-3,1'-cyclobutane]-5-yloxypyrimidin-5-yl)imidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(COC23CCC3)C2=C1 LSOZZXGDMKCFRV-MRXNPFEDSA-N 0.000 description 2
• GANVXLQPVDRZDP-QGZVFWFLSA-N (5r)-5-ethyl-3-(6-spiro[1h-2-benzofuran-3,1'-cyclobutane]-5-yloxypyridin-3-yl)imidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COC23CCC3)C2=C1 GANVXLQPVDRZDP-QGZVFWFLSA-N 0.000 description 2
• LWGBRPAONSBLOJ-CYBMUJFWSA-N (5r)-5-ethyl-3-[2-(7-methylspiro[2h-1-benzofuran-3,1'-cyclopropane]-4-yl)oxypyrimidin-5-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(C)C2=C1C1(CC1)CO2 LWGBRPAONSBLOJ-CYBMUJFWSA-N 0.000 description 2
• UTNAZRUUEYLOJF-CYBMUJFWSA-N (5r)-5-ethyl-3-[2-[(3,3,7-trimethyl-2h-1-benzofuran-4-yl)oxy]pyrimidin-5-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(C)C2=C1C(C)(C)CO2 UTNAZRUUEYLOJF-CYBMUJFWSA-N 0.000 description 2
• KUSCHUIKPGUDDF-OTOKDRCRSA-N (5r)-5-ethyl-3-[2-[(3-ethyl-1,3-dihydro-2-benzofuran-5-yl)oxy]pyrimidin-5-yl]-5-methylimidazolidine-2,4-dione Chemical compound C1=C2C(CC)OCC2=CC=C1OC(N=C1)=NC=C1N1C(=O)N[C@](C)(CC)C1=O KUSCHUIKPGUDDF-OTOKDRCRSA-N 0.000 description 2
• GGVNTEBSOURWNZ-GFCCVEGCSA-N (5r)-5-ethyl-3-[2-[4-methyl-3-(trifluoromethoxy)phenoxy]pyrimidin-5-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(C)C(OC(F)(F)F)=C1 GGVNTEBSOURWNZ-GFCCVEGCSA-N 0.000 description 2
• AMAOXEGBJHLCSF-CQSZACIVSA-N (5r)-5-ethyl-3-[6-(3-methoxy-4-methylphenoxy)pyridin-3-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C)C(OC)=C1 AMAOXEGBJHLCSF-CQSZACIVSA-N 0.000 description 2
• NPNNMBCPDXXEAG-CQSZACIVSA-N (5r)-5-ethyl-3-[6-(7-methylspiro[2h-1-benzofuran-3,1'-cyclopropane]-4-yl)oxypyridin-3-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C)C2=C1C1(CC1)CO2 NPNNMBCPDXXEAG-CQSZACIVSA-N 0.000 description 2
• YHKIKNMCENTLLI-CQSZACIVSA-N (5r)-5-ethyl-3-[6-[(3,3,7-trimethyl-2h-1-benzofuran-4-yl)oxy]pyridin-3-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C)C2=C1C(C)(C)CO2 YHKIKNMCENTLLI-CQSZACIVSA-N 0.000 description 2
• DJHFOZLDQVQSLW-GICMACPYSA-N (5r)-5-ethyl-3-[6-[(3-ethyl-1,3-dihydro-2-benzofuran-4-yl)oxy]pyridin-3-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=CC2=C1C(CC)OC2 DJHFOZLDQVQSLW-GICMACPYSA-N 0.000 description 2
• VHCQGDDHMGSPCJ-FBLFFUNLSA-N (5r)-5-ethyl-3-[6-[(3-ethyl-1,3-dihydro-2-benzofuran-5-yl)oxy]pyridin-3-yl]-5-methylimidazolidine-2,4-dione Chemical compound C1=C2C(CC)OCC2=CC=C1OC(N=C1)=CC=C1N1C(=O)N[C@](C)(CC)C1=O VHCQGDDHMGSPCJ-FBLFFUNLSA-N 0.000 description 2
• JFNGOQQEZATLIZ-CYBMUJFWSA-N (5r)-5-ethyl-3-[6-[4-methyl-3-(trifluoromethoxy)phenoxy]pyridin-3-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C)C(OC(F)(F)F)=C1 JFNGOQQEZATLIZ-CYBMUJFWSA-N 0.000 description 2
• VJORKOHZKOIAOJ-HXUWFJFHSA-N (5r)-5-ethyl-5-methyl-3-[2-(7-methylspiro[2h-1-benzofuran-3,1'-cyclopropane]-4-yl)oxypyrimidin-5-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(C)C2=C1C1(CC1)CO2 VJORKOHZKOIAOJ-HXUWFJFHSA-N 0.000 description 2
• OYFGQTVERWVDGF-OAQYLSRUSA-N (5r)-5-ethyl-5-methyl-3-[2-[(3,3,7-trimethyl-2h-1-benzofuran-4-yl)oxy]pyrimidin-5-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(C)C2=C1C(C)(C)CO2 OYFGQTVERWVDGF-OAQYLSRUSA-N 0.000 description 2
• DZJBKKVCXVSFHQ-QGZVFWFLSA-N (5r)-5-ethyl-5-methyl-3-[2-[4-methyl-3-(trifluoromethoxy)phenoxy]pyrimidin-5-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(C)C(OC(F)(F)F)=C1 DZJBKKVCXVSFHQ-QGZVFWFLSA-N 0.000 description 2
• SLCNIZVVOKLZCY-XPKAQORNSA-N (5r)-5-ethyl-5-methyl-3-[2-[[3-(trifluoromethyl)-1,3-dihydro-2-benzofuran-5-yl]oxy]pyrimidin-5-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(COC2C(F)(F)F)C2=C1 SLCNIZVVOKLZCY-XPKAQORNSA-N 0.000 description 2
• OWUGDYTUCLRMTK-MRTLOADZSA-N (5r)-5-ethyl-5-methyl-3-[2-[[3-methyl-3-(trifluoromethyl)-1h-2-benzofuran-5-yl]oxy]pyrimidin-5-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(COC2(C)C(F)(F)F)C2=C1 OWUGDYTUCLRMTK-MRTLOADZSA-N 0.000 description 2
• DLKGQKBQEFLFBQ-OTOKDRCRSA-N (5r)-5-ethyl-5-methyl-3-[5-methyl-6-[[3-(trifluoromethyl)-1,3-dihydro-2-benzofuran-5-yl]oxy]pyridin-3-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=C1C)=CN=C1OC1=CC=C(COC2C(F)(F)F)C2=C1 DLKGQKBQEFLFBQ-OTOKDRCRSA-N 0.000 description 2
• RGQNUZIWDODFPM-VQCQRNETSA-N (5r)-5-ethyl-5-methyl-3-[5-methyl-6-[[3-methyl-3-(trifluoromethyl)-1h-2-benzofuran-5-yl]oxy]pyridin-3-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=C1C)=CN=C1OC1=CC=C(COC2(C)C(F)(F)F)C2=C1 RGQNUZIWDODFPM-VQCQRNETSA-N 0.000 description 2
• CWHUKRBJRARMCX-OAQYLSRUSA-N (5r)-5-ethyl-5-methyl-3-[6-(7-methylspiro[2h-1-benzofuran-3,1'-cyclopropane]-4-yl)oxypyridin-3-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C)C2=C1C1(CC1)CO2 CWHUKRBJRARMCX-OAQYLSRUSA-N 0.000 description 2
• SNKUAWZFNNOCOP-LRTDYKAYSA-N (5r)-5-ethyl-5-methyl-3-[6-[[3-(trifluoromethyl)-1,3-dihydro-2-benzofuran-5-yl]oxy]pyridin-3-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COC2C(F)(F)F)C2=C1 SNKUAWZFNNOCOP-LRTDYKAYSA-N 0.000 description 2
• XHBQTBHBSLUMOU-FIWHBWSRSA-N (5r)-5-ethyl-5-methyl-3-[6-[[3-methyl-3-(trifluoromethyl)-1h-2-benzofuran-5-yl]oxy]pyridin-3-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COC2(C)C(F)(F)F)C2=C1 XHBQTBHBSLUMOU-FIWHBWSRSA-N 0.000 description 2
• 125000006526 (C1-C2) alkyl group Chemical group 0.000 description 2
• VDFVNEFVBPFDSB-UHFFFAOYSA-N 1,3-dioxane Chemical compound C1COCOC1 VDFVNEFVBPFDSB-UHFFFAOYSA-N 0.000 description 2
• MGADZUXDNSDTHW-UHFFFAOYSA-N 2H-pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 description 2
• BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 description 2
• PXHKOKCNQDWTHM-UHFFFAOYSA-N 3-[2-[(3-cyclopropyl-1,3-dihydro-2-benzofuran-5-yl)oxy]pyrimidin-5-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(COC2C3CC3)C2=C1 PXHKOKCNQDWTHM-UHFFFAOYSA-N 0.000 description 2
• YZAKZINCORTXJE-UHFFFAOYSA-N 3-[2-[(3-ethyl-1,3-dihydro-2-benzofuran-5-yl)oxy]pyrimidin-5-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound C1=C2C(CC)OCC2=CC=C1OC(N=C1)=NC=C1N1C(=O)NC(C)(C)C1=O YZAKZINCORTXJE-UHFFFAOYSA-N 0.000 description 2
• DHHSJNRTOWLSOO-UHFFFAOYSA-N 3-[2-[(3-tert-butyl-1,3-dihydro-2-benzofuran-5-yl)oxy]pyrimidin-5-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound C1=C2C(C(C)(C)C)OCC2=CC=C1OC(N=C1)=NC=C1N1C(=O)NC(C)(C)C1=O DHHSJNRTOWLSOO-UHFFFAOYSA-N 0.000 description 2
• CQVXHNZMCWCHQE-UHFFFAOYSA-N 3-[6-[(3-cyclopropyl-1,3-dihydro-2-benzofuran-5-yl)oxy]pyridin-3-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COC2C3CC3)C2=C1 CQVXHNZMCWCHQE-UHFFFAOYSA-N 0.000 description 2
• UTGNGYYHQDVNBY-UHFFFAOYSA-N 3-[6-[(3-ethyl-1,3-dihydro-2-benzofuran-5-yl)oxy]pyridin-3-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound C1=C2C(CC)OCC2=CC=C1OC(N=C1)=CC=C1N1C(=O)NC(C)(C)C1=O UTGNGYYHQDVNBY-UHFFFAOYSA-N 0.000 description 2
• QJEJEPKGWPVGQU-UHFFFAOYSA-N 3-methyl-4-(6-spiro[2h-1-benzofuran-3,1'-cyclopropane]-4-yloxypyridin-3-yl)-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=N1)=CC=C1OC1=CC=CC2=C1C1(CC1)CO2 QJEJEPKGWPVGQU-UHFFFAOYSA-N 0.000 description 2
• SXVVXFKHWPURFB-UHFFFAOYSA-N 3-methyl-4-[6-(7-methylspiro[2h-1-benzofuran-3,1'-cyclopropane]-4-yl)oxypyridin-3-yl]-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C)C2=C1C1(CC1)CO2 SXVVXFKHWPURFB-UHFFFAOYSA-N 0.000 description 2
• CZHVMIZYDXTWLF-UHFFFAOYSA-N 3-methyl-4-[6-[[3-methyl-3-(trifluoromethyl)-1h-2-benzofuran-5-yl]oxy]pyridin-3-yl]-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COC2(C)C(F)(F)F)C2=C1 CZHVMIZYDXTWLF-UHFFFAOYSA-N 0.000 description 2
• 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 2
• XIOQUVPRNWUTBF-QGZVFWFLSA-N 4-[5-[(4r)-4-ethyl-2,5-dioxoimidazolidin-1-yl]pyridin-2-yl]oxy-2-propan-2-ylbenzonitrile Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C(C(C)C)=C1 XIOQUVPRNWUTBF-QGZVFWFLSA-N 0.000 description 2
• IYAYIZYTDQZOAS-UHFFFAOYSA-N 4-[6-[(3-tert-butyl-1,3-dihydro-2-benzofuran-5-yl)oxy]pyridin-3-yl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COC2C(C)(C)C)C2=C1 IYAYIZYTDQZOAS-UHFFFAOYSA-N 0.000 description 2
• ABBBYWZTLYAUOM-UHFFFAOYSA-N 5,5-dimethyl-3-(6-spiro[1h-2-benzofuran-3,1'-cyclobutane]-5-yloxypyridin-3-yl)imidazolidine-2,4-dione Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COC23CCC3)C2=C1 ABBBYWZTLYAUOM-UHFFFAOYSA-N 0.000 description 2
• JYHHQTRVJFMEGR-UHFFFAOYSA-N 5,5-dimethyl-3-[2-(7-methylspiro[2h-1-benzofuran-3,1'-cyclopropane]-4-yl)oxypyrimidin-5-yl]imidazolidine-2,4-dione Chemical compound O1CC2(CC2)C2=C1C(C)=CC=C2OC(N=C1)=NC=C1N1C(=O)NC(C)(C)C1=O JYHHQTRVJFMEGR-UHFFFAOYSA-N 0.000 description 2
• RKJVNBMHIUOWSI-UHFFFAOYSA-N 5,5-dimethyl-3-[2-[4-methyl-3-(trifluoromethoxy)phenoxy]pyrimidin-5-yl]imidazolidine-2,4-dione Chemical compound C1=C(OC(F)(F)F)C(C)=CC=C1OC1=NC=C(N2C(C(C)(C)NC2=O)=O)C=N1 RKJVNBMHIUOWSI-UHFFFAOYSA-N 0.000 description 2
• JVLHFRFFZBGGJI-UHFFFAOYSA-N 5,5-dimethyl-3-[2-[[3-(trifluoromethyl)-1,3-dihydro-2-benzofuran-5-yl]oxy]pyrimidin-5-yl]imidazolidine-2,4-dione Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(COC2C(F)(F)F)C2=C1 JVLHFRFFZBGGJI-UHFFFAOYSA-N 0.000 description 2
• AARKGPHPYSFFLO-UHFFFAOYSA-N 5,5-dimethyl-3-[5-methyl-6-[[3-(trifluoromethyl)-1,3-dihydro-2-benzofuran-5-yl]oxy]pyridin-3-yl]imidazolidine-2,4-dione Chemical compound C=1N=C(OC=2C=C3C(OCC3=CC=2)C(F)(F)F)C(C)=CC=1N1C(=O)NC(C)(C)C1=O AARKGPHPYSFFLO-UHFFFAOYSA-N 0.000 description 2
• FTJZGRAFIVZFDZ-UHFFFAOYSA-N 5,5-dimethyl-3-[6-(7-methylspiro[2h-1-benzofuran-3,1'-cyclopropane]-4-yl)oxypyridin-3-yl]imidazolidine-2,4-dione Chemical compound O1CC2(CC2)C2=C1C(C)=CC=C2OC(N=C1)=CC=C1N1C(=O)NC(C)(C)C1=O FTJZGRAFIVZFDZ-UHFFFAOYSA-N 0.000 description 2
• VXCFTYWNOQFXHH-UHFFFAOYSA-N 5,5-dimethyl-3-[6-[4-methyl-3-(trifluoromethoxy)phenoxy]pyridin-3-yl]imidazolidine-2,4-dione Chemical compound C1=C(OC(F)(F)F)C(C)=CC=C1OC1=CC=C(N2C(C(C)(C)NC2=O)=O)C=N1 VXCFTYWNOQFXHH-UHFFFAOYSA-N 0.000 description 2
• HYKBZOJSLFUHPQ-UHFFFAOYSA-N 5,5-dimethyl-3-[6-[[3-(trifluoromethyl)-1,3-dihydro-2-benzofuran-5-yl]oxy]pyridin-3-yl]imidazolidine-2,4-dione Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COC2C(F)(F)F)C2=C1 HYKBZOJSLFUHPQ-UHFFFAOYSA-N 0.000 description 2
• 206010001497 Agitation Diseases 0.000 description 2
• APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 2
• 206010003591 Ataxia Diseases 0.000 description 2
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
• 206010058019 Cancer Pain Diseases 0.000 description 2
• 206010010904 Convulsion Diseases 0.000 description 2
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
• 241001661449 Espinosa Species 0.000 description 2
• 208000001640 Fibromyalgia Diseases 0.000 description 2
• 206010019233 Headaches Diseases 0.000 description 2
• 241000282412 Homo Species 0.000 description 2
• 101000654386 Homo sapiens Sodium channel protein type 9 subunit alpha Proteins 0.000 description 2
• YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
• 241000699670 Mus sp. Species 0.000 description 2
• 102000004129 N-Type Calcium Channels Human genes 0.000 description 2
• 108090000699 N-Type Calcium Channels Proteins 0.000 description 2
• ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• 108010029485 Protein Isoforms Proteins 0.000 description 2
• 102000001708 Protein Isoforms Human genes 0.000 description 2
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
• 241000283984 Rodentia Species 0.000 description 2
• 102100031367 Sodium channel protein type 9 subunit alpha Human genes 0.000 description 2
• 208000006011 Stroke Diseases 0.000 description 2
• 241000700605 Viruses Species 0.000 description 2
• 102000003734 Voltage-Gated Potassium Channels Human genes 0.000 description 2
• 108090000013 Voltage-Gated Potassium Channels Proteins 0.000 description 2
• 241000269368 Xenopus laevis Species 0.000 description 2
• 239000013543 active substance Substances 0.000 description 2
• 239000004479 aerosol dispenser Substances 0.000 description 2
• APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 2
• 229960003942 amphotericin b Drugs 0.000 description 2
• 238000002266 amputation Methods 0.000 description 2
• 238000010171 animal model Methods 0.000 description 2
• 239000003125 aqueous solvent Substances 0.000 description 2
• 210000003050 axon Anatomy 0.000 description 2
• 210000000133 brain stem Anatomy 0.000 description 2
• GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
• AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
• YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
• 125000004432 carbon atom Chemical group C* 0.000 description 2
• 230000001364 causal effect Effects 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 210000001638 cerebellum Anatomy 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 230000001684 chronic effect Effects 0.000 description 2
• 125000004122 cyclic group Chemical group 0.000 description 2
• 230000006735 deficit Effects 0.000 description 2
• 238000012217 deletion Methods 0.000 description 2
• 230000037430 deletion Effects 0.000 description 2
• 230000001419 dependent effect Effects 0.000 description 2
• 238000010790 dilution Methods 0.000 description 2
• 239000012895 dilution Substances 0.000 description 2
• 239000006185 dispersion Substances 0.000 description 2
• 238000009826 distribution Methods 0.000 description 2
• 230000003828 downregulation Effects 0.000 description 2
• 239000006196 drop Substances 0.000 description 2
• 230000004064 dysfunction Effects 0.000 description 2
• 238000002001 electrophysiology Methods 0.000 description 2
• 230000007831 electrophysiology Effects 0.000 description 2
• 150000002148 esters Chemical class 0.000 description 2
• 238000011156 evaluation Methods 0.000 description 2
• 239000012091 fetal bovine serum Substances 0.000 description 2
• 238000010304 firing Methods 0.000 description 2
• 229960002870 gabapentin Drugs 0.000 description 2
• 239000000499 gel Substances 0.000 description 2
• 239000007903 gelatin capsule Substances 0.000 description 2
• 235000011187 glycerol Nutrition 0.000 description 2
• 231100000869 headache Toxicity 0.000 description 2
• 229940091173 hydantoin Drugs 0.000 description 2
• 239000001257 hydrogen Substances 0.000 description 2
• 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
• 238000000338 in vitro Methods 0.000 description 2
• 238000011534 incubation Methods 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
• 230000000155 isotopic effect Effects 0.000 description 2
• 239000012669 liquid formulation Substances 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 230000007246 mechanism Effects 0.000 description 2
• 239000002609 medium Substances 0.000 description 2
• 239000012528 membrane Substances 0.000 description 2
• 238000000520 microinjection Methods 0.000 description 2
• 210000003205 muscle Anatomy 0.000 description 2
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
• 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
• 230000001423 neocortical effect Effects 0.000 description 2
• 210000000653 nervous system Anatomy 0.000 description 2
• 125000004433 nitrogen atom Chemical group N* 0.000 description 2
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
• 229940005483 opioid analgesics Drugs 0.000 description 2
• 230000003204 osmotic effect Effects 0.000 description 2
• 230000010412 perfusion Effects 0.000 description 2
• 210000001428 peripheral nervous system Anatomy 0.000 description 2
• 230000002085 persistent effect Effects 0.000 description 2
• 239000002953 phosphate buffered saline Substances 0.000 description 2
• 229920001223 polyethylene glycol Polymers 0.000 description 2
• 239000011148 porous material Substances 0.000 description 2
• 238000002600 positron emission tomography Methods 0.000 description 2
• 229960001233 pregabalin Drugs 0.000 description 2
• AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 description 2
• 230000036278 prepulse Effects 0.000 description 2
• 210000002248 primary sensory neuron Anatomy 0.000 description 2
• 230000008569 process Effects 0.000 description 2
• 229940002612 prodrug Drugs 0.000 description 2
• 239000000651 prodrug Substances 0.000 description 2
• 239000003380 propellant Substances 0.000 description 2
• 108090000623 proteins and genes Proteins 0.000 description 2
• 230000002336 repolarization Effects 0.000 description 2
• 238000007789 sealing Methods 0.000 description 2
• 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
• 210000003491 skin Anatomy 0.000 description 2
• 230000007958 sleep Effects 0.000 description 2
• 208000019116 sleep disease Diseases 0.000 description 2
• 239000007787 solid Substances 0.000 description 2
• 208000020431 spinal cord injury Diseases 0.000 description 2
• 210000003594 spinal ganglia Anatomy 0.000 description 2
• 239000000829 suppository Substances 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 239000003053 toxin Substances 0.000 description 2
• 231100000765 toxin Toxicity 0.000 description 2
• 108700012359 toxins Proteins 0.000 description 2
• 230000008733 trauma Effects 0.000 description 2
• FFSJPOPLSWBGQY-UHFFFAOYSA-N triazol-4-one Chemical compound O=C1C=NN=N1 FFSJPOPLSWBGQY-UHFFFAOYSA-N 0.000 description 2
• 210000001170 unmyelinated nerve fiber Anatomy 0.000 description 2
• 210000000689 upper leg Anatomy 0.000 description 2
• HFVMEOPYDLEHBR-UHFFFAOYSA-N (2-fluorophenyl)-phenylmethanol Chemical compound C=1C=CC=C(F)C=1C(O)C1=CC=CC=C1 HFVMEOPYDLEHBR-UHFFFAOYSA-N 0.000 description 1
• JESCETIFNOFKEU-SJORKVTESA-N (2s,5r)-5-[4-[(2-fluorophenyl)methoxy]phenyl]pyrrolidine-2-carboxamide Chemical compound N1[C@H](C(=O)N)CC[C@@H]1C(C=C1)=CC=C1OCC1=CC=CC=C1F JESCETIFNOFKEU-SJORKVTESA-N 0.000 description 1
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
• WRRSFOZOETZUPG-FFHNEAJVSA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;hydrate Chemical compound O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC WRRSFOZOETZUPG-FFHNEAJVSA-N 0.000 description 1
• XNTHGPIPYYQRHD-LJQANCHMSA-N (5r)-3-[2-(3-ethoxy-4-methylphenoxy)pyrimidin-5-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound C1=C(C)C(OCC)=CC(OC=2N=CC(=CN=2)N2C([C@@](C)(CC)NC2=O)=O)=C1 XNTHGPIPYYQRHD-LJQANCHMSA-N 0.000 description 1
• NOGMLHUFQIICMO-CQSZACIVSA-N (5r)-3-[2-(3-ethoxy-4-methylphenoxy)pyrimidin-5-yl]-5-ethylimidazolidine-2,4-dione Chemical compound C1=C(C)C(OCC)=CC(OC=2N=CC(=CN=2)N2C([C@@H](CC)NC2=O)=O)=C1 NOGMLHUFQIICMO-CQSZACIVSA-N 0.000 description 1
• LFBFJRDCNKBXII-MRXNPFEDSA-N (5r)-3-[2-[(2,2-difluoro-1,3-benzodioxol-4-yl)oxy]pyrimidin-5-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=CC2=C1OC(F)(F)O2 LFBFJRDCNKBXII-MRXNPFEDSA-N 0.000 description 1
• KWWAUFZMGKQKDI-OAQYLSRUSA-N (5r)-3-[2-[(3,3-diethyl-1h-2-benzofuran-5-yl)oxy]pyrimidin-5-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(COC2(CC)CC)C2=C1 KWWAUFZMGKQKDI-OAQYLSRUSA-N 0.000 description 1
• NTIWPSOEUHNVTN-OAQYLSRUSA-N (5r)-3-[2-[(3,3-dimethyl-1,4-dihydroisochromen-5-yl)oxy]pyrimidin-5-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=CC2=C1CC(C)(C)OC2 NTIWPSOEUHNVTN-OAQYLSRUSA-N 0.000 description 1
• NGNJDTAVMXCKSV-HXUWFJFHSA-N (5r)-3-[2-[(3,3-dimethyl-1h-2-benzofuran-5-yl)oxy]pyrimidin-5-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(COC2(C)C)C2=C1 NGNJDTAVMXCKSV-HXUWFJFHSA-N 0.000 description 1
• MUHADSVSTHSYGD-GFCCVEGCSA-N (5r)-3-[2-[(3,3-dimethyl-2h-1-benzofuran-4-yl)oxy]pyrimidin-5-yl]-5-ethylimidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CN=C1OC1=CC=CC2=C1C(C)(C)CO2 MUHADSVSTHSYGD-GFCCVEGCSA-N 0.000 description 1
• CLAKLXYCHLXXMD-MRXNPFEDSA-N (5r)-3-[2-[(3,3-dimethyl-2h-1-benzofuran-4-yl)oxy]pyrimidin-5-yl]-5-propan-2-ylimidazolidine-2,4-dione Chemical compound O=C1[C@@H](C(C)C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=CC2=C1C(C)(C)CO2 CLAKLXYCHLXXMD-MRXNPFEDSA-N 0.000 description 1
• VGUVXVCVUZURSD-HXUWFJFHSA-N (5r)-3-[2-[(3,3-dimethyl-2h-1-benzofuran-5-yl)oxy]pyrimidin-5-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(OCC2(C)C)C2=C1 VGUVXVCVUZURSD-HXUWFJFHSA-N 0.000 description 1
• GFTJIMPCCPRHLU-OAQYLSRUSA-N (5r)-3-[2-[(4,4-dimethyl-1,3-dihydroisochromen-6-yl)oxy]pyrimidin-5-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(COCC2(C)C)C2=C1 GFTJIMPCCPRHLU-OAQYLSRUSA-N 0.000 description 1
• DEZRPEPAVNAFNI-LLVKDONJSA-N (5r)-3-[4-(1,3-dihydro-2-benzofuran-4-yloxy)phenyl]-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@@H](C)NC(=O)N1C(C=C1)=CC=C1OC1=CC=CC2=C1COC2 DEZRPEPAVNAFNI-LLVKDONJSA-N 0.000 description 1
• WNORIHLRCGIHAT-LLVKDONJSA-N (5r)-3-[4-(1,3-dihydro-2-benzofuran-5-yloxy)phenyl]-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@@H](C)NC(=O)N1C(C=C1)=CC=C1OC1=CC=C(COC2)C2=C1 WNORIHLRCGIHAT-LLVKDONJSA-N 0.000 description 1
• HWOPDZORMNHOBO-SECBINFHSA-N (5r)-3-[4-(3-chloro-4-fluorophenoxy)phenyl]-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@@H](C)NC(=O)N1C(C=C1)=CC=C1OC1=CC=C(F)C(Cl)=C1 HWOPDZORMNHOBO-SECBINFHSA-N 0.000 description 1
• PGVUDUKVQPXCFO-SECBINFHSA-N (5r)-3-[4-(3-chloro-5-fluorophenoxy)phenyl]-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@@H](C)NC(=O)N1C(C=C1)=CC=C1OC1=CC(F)=CC(Cl)=C1 PGVUDUKVQPXCFO-SECBINFHSA-N 0.000 description 1
• VOFBDZVKZODLDO-GFCCVEGCSA-N (5r)-3-[4-(3-ethoxyphenoxy)phenyl]-5-methylimidazolidine-2,4-dione Chemical compound CCOC1=CC=CC(OC=2C=CC(=CC=2)N2C([C@@H](C)NC2=O)=O)=C1 VOFBDZVKZODLDO-GFCCVEGCSA-N 0.000 description 1
• KUQFDHVMVBOROM-GFCCVEGCSA-N (5r)-3-[4-(3-methoxy-4-methylphenoxy)phenyl]-5-methylimidazolidine-2,4-dione Chemical compound C1=C(C)C(OC)=CC(OC=2C=CC(=CC=2)N2C([C@@H](C)NC2=O)=O)=C1 KUQFDHVMVBOROM-GFCCVEGCSA-N 0.000 description 1
• BTUINUKTQKREDG-GOSISDBHSA-N (5r)-3-[4-(3-methoxy-4-methylphenoxy)phenyl]-5-propan-2-ylimidazolidine-2,4-dione Chemical compound C1=C(C)C(OC)=CC(OC=2C=CC(=CC=2)N2C([C@@H](C(C)C)NC2=O)=O)=C1 BTUINUKTQKREDG-GOSISDBHSA-N 0.000 description 1
• YEJKKCUDPQULAD-LLVKDONJSA-N (5r)-3-[4-(3-methoxyphenoxy)phenyl]-5-methylimidazolidine-2,4-dione Chemical compound COC1=CC=CC(OC=2C=CC(=CC=2)N2C([C@@H](C)NC2=O)=O)=C1 YEJKKCUDPQULAD-LLVKDONJSA-N 0.000 description 1
• AIZFJFLYQMSWPM-GFCCVEGCSA-N (5r)-3-[4-(5-methoxy-2-methylphenoxy)phenyl]-5-methylimidazolidine-2,4-dione Chemical compound COC1=CC=C(C)C(OC=2C=CC(=CC=2)N2C([C@@H](C)NC2=O)=O)=C1 AIZFJFLYQMSWPM-GFCCVEGCSA-N 0.000 description 1
• JYJGIGZDJIZOOU-GFCCVEGCSA-N (5r)-3-[4-[(3,3-dimethyl-2h-1-benzofuran-4-yl)oxy]phenyl]-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@@H](C)NC(=O)N1C(C=C1)=CC=C1OC1=CC=CC2=C1C(C)(C)CO2 JYJGIGZDJIZOOU-GFCCVEGCSA-N 0.000 description 1
• BHSLNPYKWBHNJV-GFCCVEGCSA-N (5r)-3-[4-[(3,6-dimethyl-1,2-benzoxazol-4-yl)oxy]phenyl]-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@@H](C)NC(=O)N1C(C=C1)=CC=C1OC1=CC(C)=CC2=C1C(C)=NO2 BHSLNPYKWBHNJV-GFCCVEGCSA-N 0.000 description 1
• KONDTIQYPDHQQI-GFCCVEGCSA-N (5r)-3-[6-(2,3-dimethylphenoxy)pyridin-3-yl]-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@@H](C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=CC(C)=C1C KONDTIQYPDHQQI-GFCCVEGCSA-N 0.000 description 1
• XLLHUAOUVJTIOP-GFCCVEGCSA-N (5r)-3-[6-(2,5-dimethylphenoxy)pyridin-3-yl]-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@@H](C)NC(=O)N1C(C=N1)=CC=C1OC1=CC(C)=CC=C1C XLLHUAOUVJTIOP-GFCCVEGCSA-N 0.000 description 1
• UPBAATQVFMUENK-GFCCVEGCSA-N (5r)-3-[6-(2,6-dimethylphenoxy)pyridin-3-yl]-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@@H](C)NC(=O)N1C(C=N1)=CC=C1OC1=C(C)C=CC=C1C UPBAATQVFMUENK-GFCCVEGCSA-N 0.000 description 1
• NCKSBRYDEQEYRF-LLVKDONJSA-N (5r)-3-[6-(2-ethylphenoxy)pyridin-3-yl]-5-methylimidazolidine-2,4-dione Chemical compound CCC1=CC=CC=C1OC1=CC=C(N2C([C@@H](C)NC2=O)=O)C=N1 NCKSBRYDEQEYRF-LLVKDONJSA-N 0.000 description 1
• KYOIAWOEBRWZCH-LLVKDONJSA-N (5r)-3-[6-(3-methoxy-2-methylphenoxy)pyridin-3-yl]-5-methylimidazolidine-2,4-dione Chemical compound COC1=CC=CC(OC=2N=CC(=CC=2)N2C([C@@H](C)NC2=O)=O)=C1C KYOIAWOEBRWZCH-LLVKDONJSA-N 0.000 description 1
• RAVHFGXUBIHMHW-LLVKDONJSA-N (5r)-3-[6-(3-methoxy-4-methylphenoxy)pyridin-3-yl]-5-methylimidazolidine-2,4-dione Chemical compound C1=C(C)C(OC)=CC(OC=2N=CC(=CC=2)N2C([C@@H](C)NC2=O)=O)=C1 RAVHFGXUBIHMHW-LLVKDONJSA-N 0.000 description 1
• NMDUDTOVZPJHQQ-QGZVFWFLSA-N (5r)-3-[6-(3-methoxy-4-methylphenoxy)pyridin-3-yl]-5-propan-2-ylimidazolidine-2,4-dione Chemical compound C1=C(C)C(OC)=CC(OC=2N=CC(=CC=2)N2C([C@@H](C(C)C)NC2=O)=O)=C1 NMDUDTOVZPJHQQ-QGZVFWFLSA-N 0.000 description 1
• CEWFNICOTBKTGJ-LLVKDONJSA-N (5r)-3-[6-(5-methoxy-2-methylphenoxy)pyridin-3-yl]-5-methylimidazolidine-2,4-dione Chemical compound COC1=CC=C(C)C(OC=2N=CC(=CC=2)N2C([C@@H](C)NC2=O)=O)=C1 CEWFNICOTBKTGJ-LLVKDONJSA-N 0.000 description 1
• CWQPAXHEMUDEFM-CQSZACIVSA-N (5r)-3-[6-[(2,2-dimethyl-3h-1-benzofuran-4-yl)oxy]pyridin-3-yl]-5-ethylimidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=CC2=C1CC(C)(C)O2 CWQPAXHEMUDEFM-CQSZACIVSA-N 0.000 description 1
• NXFZEVSAUSOECI-JOCHJYFZSA-N (5r)-3-[6-[(3,3-diethyl-1h-2-benzofuran-4-yl)oxy]pyridin-3-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=CC2=C1C(CC)(CC)OC2 NXFZEVSAUSOECI-JOCHJYFZSA-N 0.000 description 1
• QOHXMTCRAKZKAS-JOCHJYFZSA-N (5r)-3-[6-[(3,3-diethyl-1h-2-benzofuran-5-yl)oxy]pyridin-3-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COC2(CC)CC)C2=C1 QOHXMTCRAKZKAS-JOCHJYFZSA-N 0.000 description 1
• JXNSTUBOQNDSKJ-JOCHJYFZSA-N (5r)-3-[6-[(3,3-dimethyl-1,4-dihydroisochromen-5-yl)oxy]pyridin-3-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=CC2=C1CC(C)(C)OC2 JXNSTUBOQNDSKJ-JOCHJYFZSA-N 0.000 description 1
• QHYRGKMMPURNST-OAQYLSRUSA-N (5r)-3-[6-[(3,3-dimethyl-1h-2-benzofuran-4-yl)oxy]pyridin-3-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=CC2=C1C(C)(C)OC2 QHYRGKMMPURNST-OAQYLSRUSA-N 0.000 description 1
• YLINUWFWUKIGBS-JOCHJYFZSA-N (5r)-3-[6-[(3,3-dimethyl-1h-2-benzofuran-5-yl)oxy]-5-methylpyridin-3-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=C1C)=CN=C1OC1=CC=C(COC2(C)C)C2=C1 YLINUWFWUKIGBS-JOCHJYFZSA-N 0.000 description 1
• BANNWOFBMMRBFI-CYBMUJFWSA-N (5r)-3-[6-[(3,3-dimethyl-2h-1-benzofuran-4-yl)oxy]pyridin-3-yl]-5-ethylimidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=CC2=C1C(C)(C)CO2 BANNWOFBMMRBFI-CYBMUJFWSA-N 0.000 description 1
• UFXXLHLRZQDWQK-LLVKDONJSA-N (5r)-3-[6-[(3,3-dimethyl-2h-1-benzofuran-4-yl)oxy]pyridin-3-yl]-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@@H](C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=CC2=C1C(C)(C)CO2 UFXXLHLRZQDWQK-LLVKDONJSA-N 0.000 description 1
• AIKOGQLXSXLSOR-OAQYLSRUSA-N (5r)-3-[6-[(3,3-dimethyl-2h-1-benzofuran-5-yl)oxy]pyridin-3-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(OCC2(C)C)C2=C1 AIKOGQLXSXLSOR-OAQYLSRUSA-N 0.000 description 1
• KAAGFQARPRFVCV-OAHLLOKOSA-N (5r)-3-[6-[(3,3-dimethyl-2h-1-benzofuran-5-yl)oxy]pyridin-3-yl]-5-ethylimidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(OCC2(C)C)C2=C1 KAAGFQARPRFVCV-OAHLLOKOSA-N 0.000 description 1
• ODYDLICXEYJNPP-JOCHJYFZSA-N (5r)-3-[6-[(4,4-dimethyl-1,3-dihydroisochromen-6-yl)oxy]pyridin-3-yl]-5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COCC2(C)C)C2=C1 ODYDLICXEYJNPP-JOCHJYFZSA-N 0.000 description 1
• XOWFIAMSTPQWIU-CYBMUJFWSA-N (5r)-5-ethyl-3-(6-spiro[2h-1-benzofuran-3,1'-cyclopropane]-4-yloxypyridin-3-yl)imidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=CC2=C1C1(CC1)CO2 XOWFIAMSTPQWIU-CYBMUJFWSA-N 0.000 description 1
• AKWYPYSMNSSAHJ-GOSISDBHSA-N (5r)-5-ethyl-3-[2-(3-methoxy-4-methylphenoxy)pyrimidin-5-yl]-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(C)C(OC)=C1 AKWYPYSMNSSAHJ-GOSISDBHSA-N 0.000 description 1
• IRJYSDMKZFFBSU-MRXNPFEDSA-N (5r)-5-ethyl-3-[4-(3-methoxyphenoxy)phenyl]imidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=C1)=CC=C1OC1=CC=CC(OC)=C1 IRJYSDMKZFFBSU-MRXNPFEDSA-N 0.000 description 1
• HAAFWNXQOYAZML-LJQANCHMSA-N (5r)-5-ethyl-3-[6-(3-methoxy-4-methylphenoxy)pyridin-3-yl]-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C)C(OC)=C1 HAAFWNXQOYAZML-LJQANCHMSA-N 0.000 description 1
• LEPKEFFNGWOANC-MRXNPFEDSA-N (5r)-5-ethyl-3-[6-(3-propan-2-ylphenoxy)pyridin-3-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=CC(C(C)C)=C1 LEPKEFFNGWOANC-MRXNPFEDSA-N 0.000 description 1
• UCUCGUSVXQPQHJ-CYBMUJFWSA-N (5r)-5-ethyl-3-[6-[(3-ethyl-1,2-benzoxazol-4-yl)oxy]pyridin-3-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=CC2=C1C(CC)=NO2 UCUCGUSVXQPQHJ-CYBMUJFWSA-N 0.000 description 1
• SUGOIOCOVYLITH-SBXXRYSUSA-N (5r)-5-ethyl-3-[6-[(3-methyl-1,3-dihydro-2-benzofuran-4-yl)oxy]pyridin-3-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=CC2=C1C(C)OC2 SUGOIOCOVYLITH-SBXXRYSUSA-N 0.000 description 1
• KGOZBBRMSFXYCI-CYBMUJFWSA-N (5r)-5-ethyl-3-[6-[(3-propan-2-yl-1,2-benzoxazol-4-yl)oxy]pyridin-3-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=CC2=C1C(C(C)C)=NO2 KGOZBBRMSFXYCI-CYBMUJFWSA-N 0.000 description 1
• MJACQPDTJQZOIH-HXUWFJFHSA-N (5r)-5-ethyl-5-methyl-3-(2-spiro[1h-2-benzofuran-3,1'-cyclobutane]-5-yloxypyrimidin-5-yl)imidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(COC23CCC3)C2=C1 MJACQPDTJQZOIH-HXUWFJFHSA-N 0.000 description 1
• NCCOXRAOCBVOBG-OAQYLSRUSA-N (5r)-5-ethyl-5-methyl-3-(2-spiro[1h-2-benzofuran-3,1'-cyclopentane]-5-yloxypyrimidin-5-yl)imidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(COC23CCCC3)C2=C1 NCCOXRAOCBVOBG-OAQYLSRUSA-N 0.000 description 1
• ACUNKDPNYHBFML-JOCHJYFZSA-N (5r)-5-ethyl-5-methyl-3-(5-methyl-6-spiro[1h-2-benzofuran-3,1'-cyclobutane]-5-yloxypyridin-3-yl)imidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=C1C)=CN=C1OC1=CC=C(COC23CCC3)C2=C1 ACUNKDPNYHBFML-JOCHJYFZSA-N 0.000 description 1
• JBQMXBQRWQJAQB-OAQYLSRUSA-N (5r)-5-ethyl-5-methyl-3-(6-spiro[1,3-dihydroisochromene-4,1'-cyclopropane]-5-yloxypyridin-3-yl)imidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=CC2=C1C1(CC1)COC2 JBQMXBQRWQJAQB-OAQYLSRUSA-N 0.000 description 1
• IHUKOBHPRYNGAA-OAQYLSRUSA-N (5r)-5-ethyl-5-methyl-3-(6-spiro[1h-2-benzofuran-3,1'-cyclobutane]-5-yloxypyridin-3-yl)imidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COC23CCC3)C2=C1 IHUKOBHPRYNGAA-OAQYLSRUSA-N 0.000 description 1
• NJSFHPVYLAMHCN-JOCHJYFZSA-N (5r)-5-ethyl-5-methyl-3-(6-spiro[1h-2-benzofuran-3,1'-cyclopentane]-5-yloxypyridin-3-yl)imidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COC23CCCC3)C2=C1 NJSFHPVYLAMHCN-JOCHJYFZSA-N 0.000 description 1
• CPDWLGQBLZMRST-HXUWFJFHSA-N (5r)-5-ethyl-5-methyl-3-(6-spiro[2h-1-benzofuran-3,1'-cyclopropane]-4-yloxypyridin-3-yl)imidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=CC2=C1C1(CC1)CO2 CPDWLGQBLZMRST-HXUWFJFHSA-N 0.000 description 1
• MDESKNKMZVMFSF-OAQYLSRUSA-N (5r)-5-ethyl-5-methyl-3-[2-(7-methylspiro[1h-2-benzofuran-3,1'-cyclobutane]-4-yl)oxypyrimidin-5-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(C)C2=C1C1(CCC1)OC2 MDESKNKMZVMFSF-OAQYLSRUSA-N 0.000 description 1
• WGUQZTNFOFTICR-VLFLDKFOSA-N (5r)-5-ethyl-5-methyl-3-[2-[(4-methyl-3,4-dihydro-2h-chromen-5-yl)oxy]pyrimidin-5-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=CC2=C1C(C)CCO2 WGUQZTNFOFTICR-VLFLDKFOSA-N 0.000 description 1
• JSJIKXPDVCODPV-LLVKDONJSA-N (5r)-5-methyl-3-[2-(3-propan-2-ylphenoxy)pyrimidin-5-yl]imidazolidine-2,4-dione Chemical compound CC(C)C1=CC=CC(OC=2N=CC(=CN=2)N2C([C@@H](C)NC2=O)=O)=C1 JSJIKXPDVCODPV-LLVKDONJSA-N 0.000 description 1
• RQZBWTHEVBEERL-GFCCVEGCSA-N (5r)-5-methyl-3-[4-(3-methylphenoxy)phenyl]imidazolidine-2,4-dione Chemical compound O=C1[C@@H](C)NC(=O)N1C(C=C1)=CC=C1OC1=CC=CC(C)=C1 RQZBWTHEVBEERL-GFCCVEGCSA-N 0.000 description 1
• WBZCSPNCZZLTMR-LLVKDONJSA-N (5r)-5-methyl-3-[4-[(3-methyl-1,2-benzoxazol-4-yl)oxy]phenyl]imidazolidine-2,4-dione Chemical compound O=C1[C@@H](C)NC(=O)N1C(C=C1)=CC=C1OC1=CC=CC2=C1C(C)=NO2 WBZCSPNCZZLTMR-LLVKDONJSA-N 0.000 description 1
• GFRIXFDKZVOXAV-GFCCVEGCSA-N (5r)-5-methyl-3-[6-(3-propan-2-yloxyphenoxy)pyridin-3-yl]imidazolidine-2,4-dione Chemical compound CC(C)OC1=CC=CC(OC=2N=CC(=CC=2)N2C([C@@H](C)NC2=O)=O)=C1 GFRIXFDKZVOXAV-GFCCVEGCSA-N 0.000 description 1
• LWIDVJYEQMQSQO-GFCCVEGCSA-N (5r)-5-methyl-3-[6-(3-propan-2-ylphenoxy)pyridin-3-yl]imidazolidine-2,4-dione Chemical compound CC(C)C1=CC=CC(OC=2N=CC(=CC=2)N2C([C@@H](C)NC2=O)=O)=C1 LWIDVJYEQMQSQO-GFCCVEGCSA-N 0.000 description 1
• NPLOCGGQYSBOPP-INIZCTEOSA-N (5r)-5-tert-butyl-3-[2-[(3,3-dimethyl-2h-1-benzofuran-4-yl)oxy]pyrimidin-5-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@@H](C(C)(C)C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=CC2=C1C(C)(C)CO2 NPLOCGGQYSBOPP-INIZCTEOSA-N 0.000 description 1
• LFVFRVPCLHKIJN-KRWDZBQOSA-N (5r)-5-tert-butyl-3-[6-(3-methoxy-4-methylphenoxy)pyridin-3-yl]imidazolidine-2,4-dione Chemical compound C1=C(C)C(OC)=CC(OC=2N=CC(=CC=2)N2C([C@H](NC2=O)C(C)(C)C)=O)=C1 LFVFRVPCLHKIJN-KRWDZBQOSA-N 0.000 description 1
• HWOPDZORMNHOBO-VIFPVBQESA-N (5s)-3-[4-(3-chloro-4-fluorophenoxy)phenyl]-5-methylimidazolidine-2,4-dione Chemical compound O=C1[C@H](C)NC(=O)N1C(C=C1)=CC=C1OC1=CC=C(F)C(Cl)=C1 HWOPDZORMNHOBO-VIFPVBQESA-N 0.000 description 1
• AMAOXEGBJHLCSF-AWEZNQCLSA-N (5s)-5-ethyl-3-[6-(3-methoxy-4-methylphenoxy)pyridin-3-yl]imidazolidine-2,4-dione Chemical compound O=C1[C@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C)C(OC)=C1 AMAOXEGBJHLCSF-AWEZNQCLSA-N 0.000 description 1
• TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 description 1
• ZEUITGRIYCTCEM-KRWDZBQOSA-N (S)-duloxetine Chemical compound C1([C@@H](OC=2C3=CC=CC=C3C=CC=2)CCNC)=CC=CS1 ZEUITGRIYCTCEM-KRWDZBQOSA-N 0.000 description 1
• MDTUWBLTRPRXBX-UHFFFAOYSA-N 1,2,4-triazol-3-one Chemical compound O=C1N=CN=N1 MDTUWBLTRPRXBX-UHFFFAOYSA-N 0.000 description 1
• WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
• IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
• HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
• YOCKBSZZVQTBRN-UHFFFAOYSA-N 2-(cyclopropylmethoxy)-4-[5-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)pyridin-2-yl]oxybenzonitrile Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C(OCC2CC2)=C1 YOCKBSZZVQTBRN-UHFFFAOYSA-N 0.000 description 1
• DIANCTPWMPZGRV-QGZVFWFLSA-N 2-(cyclopropylmethoxy)-4-[5-[(4r)-4-ethyl-2,5-dioxoimidazolidin-1-yl]pyridin-2-yl]oxybenzonitrile Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C(OCC2CC2)=C1 DIANCTPWMPZGRV-QGZVFWFLSA-N 0.000 description 1
• MVBCYOZHSZJHPW-UHFFFAOYSA-N 2-chloro-4-[5-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)pyridin-2-yl]oxybenzonitrile Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C(Cl)=C1 MVBCYOZHSZJHPW-UHFFFAOYSA-N 0.000 description 1
• KETYWOVNCSJMAM-UHFFFAOYSA-N 2-cyclopropyl-4-[5-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)pyridin-2-yl]oxybenzonitrile Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C(C2CC2)=C1 KETYWOVNCSJMAM-UHFFFAOYSA-N 0.000 description 1
• IFVGENLCCIDWSC-QGZVFWFLSA-N 2-cyclopropyl-4-[5-[(4r)-4-ethyl-2,5-dioxoimidazolidin-1-yl]pyridin-2-yl]oxybenzonitrile Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C(C2CC2)=C1 IFVGENLCCIDWSC-QGZVFWFLSA-N 0.000 description 1
• PJSLFSSZSJWJOF-OAQYLSRUSA-N 2-cyclopropyl-4-[5-[(4r)-4-ethyl-4-methyl-2,5-dioxoimidazolidin-1-yl]pyridin-2-yl]oxybenzonitrile Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C(C2CC2)=C1 PJSLFSSZSJWJOF-OAQYLSRUSA-N 0.000 description 1
• OFQLTGHXESVGHO-QGZVFWFLSA-N 2-ethoxy-4-[4-[(4r)-4-ethyl-2,5-dioxoimidazolidin-1-yl]phenoxy]benzonitrile Chemical compound C1=C(C#N)C(OCC)=CC(OC=2C=CC(=CC=2)N2C([C@@H](CC)NC2=O)=O)=C1 OFQLTGHXESVGHO-QGZVFWFLSA-N 0.000 description 1
• KGWNRZLPXLBMPS-UHFFFAOYSA-N 2h-1,3-oxazine Chemical compound C1OC=CC=N1 KGWNRZLPXLBMPS-UHFFFAOYSA-N 0.000 description 1
• LFHIGAAFNQHUPC-UHFFFAOYSA-N 3-[2-(2-tert-butylphenoxy)pyrimidin-5-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC(C)(C)C1=CC=CC=C1OC1=NC=C(N2C(C(C)(C)NC2=O)=O)C=N1 LFHIGAAFNQHUPC-UHFFFAOYSA-N 0.000 description 1
• HLDVEENPMLMRSM-UHFFFAOYSA-N 3-[2-[(3,3-diethyl-1h-2-benzofuran-5-yl)oxy]pyrimidin-5-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound C1=C2C(CC)(CC)OCC2=CC=C1OC(N=C1)=NC=C1N1C(=O)NC(C)(C)C1=O HLDVEENPMLMRSM-UHFFFAOYSA-N 0.000 description 1
• ZICPNWSAKOAKBG-UHFFFAOYSA-N 3-[2-[(3,3-dimethyl-1,4-dihydroisochromen-5-yl)oxy]pyrimidin-5-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=CC2=C1CC(C)(C)OC2 ZICPNWSAKOAKBG-UHFFFAOYSA-N 0.000 description 1
• GZJTXYMLKLJLEO-UHFFFAOYSA-N 3-[2-[(3,3-dimethyl-1h-2-benzofuran-5-yl)oxy]pyrimidin-5-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(COC2(C)C)C2=C1 GZJTXYMLKLJLEO-UHFFFAOYSA-N 0.000 description 1
• RLZSNZIJMXBLGI-UHFFFAOYSA-N 3-[2-[(3,3-dimethyl-2h-1-benzofuran-4-yl)oxy]pyrimidin-5-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound C=12C(C)(C)COC2=CC=CC=1OC(N=C1)=NC=C1N1C(=O)NC(C)(C)C1=O RLZSNZIJMXBLGI-UHFFFAOYSA-N 0.000 description 1
• UTOYMVFQCHDTBV-UHFFFAOYSA-N 3-[2-[(3,3-dimethyl-2h-1-benzofuran-5-yl)oxy]pyrimidin-5-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound C1=C2C(C)(C)COC2=CC=C1OC(N=C1)=NC=C1N1C(=O)NC(C)(C)C1=O UTOYMVFQCHDTBV-UHFFFAOYSA-N 0.000 description 1
• DCQVJUJQVJIWPU-UHFFFAOYSA-N 3-[2-[(4,4-dimethyl-1,3-dihydroisochromen-6-yl)oxy]pyrimidin-5-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(COCC2(C)C)C2=C1 DCQVJUJQVJIWPU-UHFFFAOYSA-N 0.000 description 1
• AUXBXMMBVFFUDC-UHFFFAOYSA-N 3-[4-(2,3-dimethylphenoxy)phenyl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1=CC=CC(OC=2C=CC(=CC=2)N2C(C(C)(C)NC2=O)=O)=C1C AUXBXMMBVFFUDC-UHFFFAOYSA-N 0.000 description 1
• HZFREJQRDWQGQC-UHFFFAOYSA-N 3-[4-(3-methoxyphenoxy)phenyl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound COC1=CC=CC(OC=2C=CC(=CC=2)N2C(C(C)(C)NC2=O)=O)=C1 HZFREJQRDWQGQC-UHFFFAOYSA-N 0.000 description 1
• ZJXSKCKSDWJWDC-UHFFFAOYSA-N 3-[6-(2,6-dimethylphenoxy)pyridin-3-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1=CC=CC(C)=C1OC1=CC=C(N2C(C(C)(C)NC2=O)=O)C=N1 ZJXSKCKSDWJWDC-UHFFFAOYSA-N 0.000 description 1
• VOSXOXREFBURNW-UHFFFAOYSA-N 3-[6-(2-ethylphenoxy)pyridin-3-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound CCC1=CC=CC=C1OC1=CC=C(N2C(C(C)(C)NC2=O)=O)C=N1 VOSXOXREFBURNW-UHFFFAOYSA-N 0.000 description 1
• KSMIANBVHCJDAE-UHFFFAOYSA-N 3-[6-(2-tert-butylphenoxy)pyridin-3-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC(C)(C)C1=CC=CC=C1OC1=CC=C(N2C(C(C)(C)NC2=O)=O)C=N1 KSMIANBVHCJDAE-UHFFFAOYSA-N 0.000 description 1
• ZLWGIWYMUMSEPL-UHFFFAOYSA-N 3-[6-(3-methoxy-4-methylphenoxy)pyridin-3-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound C1=C(C)C(OC)=CC(OC=2N=CC(=CC=2)N2C(C(C)(C)NC2=O)=O)=C1 ZLWGIWYMUMSEPL-UHFFFAOYSA-N 0.000 description 1
• HUZHREYEKKIFDK-UHFFFAOYSA-N 3-[6-(4-fluoro-2-methylphenoxy)pyridin-3-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1=CC(F)=CC=C1OC1=CC=C(N2C(C(C)(C)NC2=O)=O)C=N1 HUZHREYEKKIFDK-UHFFFAOYSA-N 0.000 description 1
• JRKBEQDYCHETRX-UHFFFAOYSA-N 3-[6-(4-fluoro-3-methylphenoxy)pyridin-3-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound C1=C(F)C(C)=CC(OC=2N=CC(=CC=2)N2C(C(C)(C)NC2=O)=O)=C1 JRKBEQDYCHETRX-UHFFFAOYSA-N 0.000 description 1
• HMLJINRNVYUTBC-UHFFFAOYSA-N 3-[6-[(3,3-diethyl-1h-2-benzofuran-5-yl)oxy]pyridin-3-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound C1=C2C(CC)(CC)OCC2=CC=C1OC(N=C1)=CC=C1N1C(=O)NC(C)(C)C1=O HMLJINRNVYUTBC-UHFFFAOYSA-N 0.000 description 1
• QKKIXMMFPYSTEH-UHFFFAOYSA-N 3-[6-[(3,3-dimethyl-2h-1-benzofuran-4-yl)oxy]pyridin-3-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound C=12C(C)(C)COC2=CC=CC=1OC(N=C1)=CC=C1N1C(=O)NC(C)(C)C1=O QKKIXMMFPYSTEH-UHFFFAOYSA-N 0.000 description 1
• CPGJUZILFONYDJ-UHFFFAOYSA-N 3-[6-[(3,3-dimethyl-2h-1-benzofuran-5-yl)oxy]pyridin-3-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound C1=C2C(C)(C)COC2=CC=C1OC(N=C1)=CC=C1N1C(=O)NC(C)(C)C1=O CPGJUZILFONYDJ-UHFFFAOYSA-N 0.000 description 1
• AOZHFMOQYJFMFL-UHFFFAOYSA-N 3-[6-[(3-ethyl-1,3-dihydro-2-benzofuran-4-yl)oxy]pyridin-3-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound C=12C(CC)OCC2=CC=CC=1OC(N=C1)=CC=C1N1C(=O)NC(C)(C)C1=O AOZHFMOQYJFMFL-UHFFFAOYSA-N 0.000 description 1
• BLQYVYOXUXLEPY-UHFFFAOYSA-N 3-[6-[(4,4-dimethyl-1,3-dihydroisochromen-6-yl)oxy]pyridin-3-yl]-5,5-dimethylimidazolidine-2,4-dione Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COCC2(C)C)C2=C1 BLQYVYOXUXLEPY-UHFFFAOYSA-N 0.000 description 1
• BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
• JLVBTFUDNJDEAY-UHFFFAOYSA-N 3-cyclopropyl-4-[5-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)pyridin-2-yl]oxybenzonitrile Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C=C1C1CC1 JLVBTFUDNJDEAY-UHFFFAOYSA-N 0.000 description 1
• YZNFLTVYWZJMHZ-MRXNPFEDSA-N 3-cyclopropyl-4-[5-[(4r)-4-ethyl-2,5-dioxoimidazolidin-1-yl]pyridin-2-yl]oxybenzonitrile Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C=C1C1CC1 YZNFLTVYWZJMHZ-MRXNPFEDSA-N 0.000 description 1
• CHRRBXGDIYARAF-OAQYLSRUSA-N 3-cyclopropyl-4-[5-[(4r)-4-ethyl-4-methyl-2,5-dioxoimidazolidin-1-yl]pyridin-2-yl]oxybenzonitrile Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C=C1C1CC1 CHRRBXGDIYARAF-OAQYLSRUSA-N 0.000 description 1
• UCTNKLVIRGQNMD-CQSZACIVSA-N 3-ethyl-4-[5-[(4r)-4-ethyl-2,5-dioxoimidazolidin-1-yl]pyrimidin-2-yl]oxybenzonitrile Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(C#N)C=C1CC UCTNKLVIRGQNMD-CQSZACIVSA-N 0.000 description 1
• SWCKNZPFWDTENM-UHFFFAOYSA-N 3-methyl-4-(5-methyl-6-spiro[2h-1-benzofuran-3,1'-cyclopropane]-4-yloxypyridin-3-yl)-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1C)=CN=C1OC1=CC=CC2=C1C1(CC1)CO2 SWCKNZPFWDTENM-UHFFFAOYSA-N 0.000 description 1
• MAYXIKTYUMBPIQ-UHFFFAOYSA-N 3-methyl-4-(6-spiro[1h-2-benzofuran-3,1'-cyclobutane]-5-yloxypyridin-3-yl)-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COC23CCC3)C2=C1 MAYXIKTYUMBPIQ-UHFFFAOYSA-N 0.000 description 1
• BDINBEGKCACPFR-UHFFFAOYSA-N 3-methyl-4-[2-(7-methylspiro[2h-1-benzofuran-3,1'-cyclopropane]-4-yl)oxypyrimidin-5-yl]-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=N1)=CN=C1OC1=CC=C(C)C2=C1C1(CC1)CO2 BDINBEGKCACPFR-UHFFFAOYSA-N 0.000 description 1
• OKLXJCHECGELKY-UHFFFAOYSA-N 3-methyl-4-[4-(2-methylphenoxy)phenyl]-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1)=CC=C1OC1=CC=CC=C1C OKLXJCHECGELKY-UHFFFAOYSA-N 0.000 description 1
• JPCZXWMSLWBUPH-UHFFFAOYSA-N 3-methyl-4-[4-(3-methylphenoxy)phenyl]-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1)=CC=C1OC1=CC=CC(C)=C1 JPCZXWMSLWBUPH-UHFFFAOYSA-N 0.000 description 1
• CRDQQBJKVMJSBK-UHFFFAOYSA-N 3-methyl-4-[4-(3-propan-2-ylphenoxy)phenyl]-1h-1,2,4-triazol-5-one Chemical compound CC(C)C1=CC=CC(OC=2C=CC(=CC=2)N2C(NN=C2C)=O)=C1 CRDQQBJKVMJSBK-UHFFFAOYSA-N 0.000 description 1
• KURMQXDUSWKHDV-UHFFFAOYSA-N 3-methyl-4-[4-[3-(trifluoromethoxy)phenoxy]phenyl]-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1)=CC=C1OC1=CC=CC(OC(F)(F)F)=C1 KURMQXDUSWKHDV-UHFFFAOYSA-N 0.000 description 1
• HAEHOTBKQOTAMS-UHFFFAOYSA-N 3-methyl-4-[4-[3-(trifluoromethyl)phenoxy]phenyl]-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 HAEHOTBKQOTAMS-UHFFFAOYSA-N 0.000 description 1
• RPSAGKHXCFJOSR-UHFFFAOYSA-N 3-methyl-4-[5-methyl-6-(3-propan-2-ylphenoxy)pyridin-3-yl]-1h-1,2,4-triazol-5-one Chemical compound CC(C)C1=CC=CC(OC=2C(=CC(=CN=2)N2C(NN=C2C)=O)C)=C1 RPSAGKHXCFJOSR-UHFFFAOYSA-N 0.000 description 1
• MLVZXLGUAWWQTM-UHFFFAOYSA-N 3-methyl-4-[5-methyl-6-(7-methylspiro[2h-1-benzofuran-3,1'-cyclopropane]-4-yl)oxypyridin-3-yl]-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1C)=CN=C1OC1=CC=C(C)C2=C1C1(CC1)CO2 MLVZXLGUAWWQTM-UHFFFAOYSA-N 0.000 description 1
• AEWMLCWSDURMER-UHFFFAOYSA-N 3-methyl-4-[6-(3-propan-2-ylphenoxy)pyridin-3-yl]-1H-1,2,4-triazol-5-one Chemical compound CC(C)c1cccc(Oc2ccc(cn2)-n2c(C)n[nH]c2=O)c1 AEWMLCWSDURMER-UHFFFAOYSA-N 0.000 description 1
• QYACMTXZEJKARP-UHFFFAOYSA-N 3-methyl-4-[6-[(3,3,7-trimethyl-2h-1-benzofuran-4-yl)oxy]pyridin-3-yl]-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C)C2=C1C(C)(C)CO2 QYACMTXZEJKARP-UHFFFAOYSA-N 0.000 description 1
• KSWCRXAOXLLWTG-UHFFFAOYSA-N 3-methyl-4-[6-[4-methyl-3-(trifluoromethoxy)phenoxy]pyridin-3-yl]-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C)C(OC(F)(F)F)=C1 KSWCRXAOXLLWTG-UHFFFAOYSA-N 0.000 description 1
• YFODXLLLDSUCFY-UHFFFAOYSA-N 3-tert-butyl-4-[5-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)pyridin-2-yl]oxybenzonitrile Chemical compound CC(C)(C)C1=CC(C#N)=CC=C1OC1=CC=C(N2C(C(C)(C)NC2=O)=O)C=N1 YFODXLLLDSUCFY-UHFFFAOYSA-N 0.000 description 1
• QDWFCRVEPXMYAE-UHFFFAOYSA-N 3-tert-butyl-4-[5-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)pyrimidin-2-yl]oxybenzonitrile Chemical compound CC(C)(C)C1=CC(C#N)=CC=C1OC1=NC=C(N2C(C(C)(C)NC2=O)=O)C=N1 QDWFCRVEPXMYAE-UHFFFAOYSA-N 0.000 description 1
• ZDBJBLOEPMEJRH-MRXNPFEDSA-N 3-tert-butyl-4-[5-[(4r)-4-ethyl-2,5-dioxoimidazolidin-1-yl]pyridin-2-yl]oxybenzonitrile Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C=C1C(C)(C)C ZDBJBLOEPMEJRH-MRXNPFEDSA-N 0.000 description 1
• KNNIEVJMDXYPIA-OAHLLOKOSA-N 3-tert-butyl-4-[5-[(4r)-4-ethyl-2,5-dioxoimidazolidin-1-yl]pyrimidin-2-yl]oxybenzonitrile Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(C#N)C=C1C(C)(C)C KNNIEVJMDXYPIA-OAHLLOKOSA-N 0.000 description 1
• DRMIXJRAJGCOJO-JOCHJYFZSA-N 3-tert-butyl-4-[5-[(4r)-4-ethyl-4-methyl-2,5-dioxoimidazolidin-1-yl]pyridin-2-yl]oxybenzonitrile Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C=C1C(C)(C)C DRMIXJRAJGCOJO-JOCHJYFZSA-N 0.000 description 1
• WVFORLMTMXTDAJ-OAQYLSRUSA-N 3-tert-butyl-4-[5-[(4r)-4-ethyl-4-methyl-2,5-dioxoimidazolidin-1-yl]pyrimidin-2-yl]oxybenzonitrile Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(C#N)C=C1C(C)(C)C WVFORLMTMXTDAJ-OAQYLSRUSA-N 0.000 description 1
• NJRMOMWWHLVMPA-UHFFFAOYSA-N 4-[4-(2,3-dimethylphenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1)=CC=C1OC1=CC=CC(C)=C1C NJRMOMWWHLVMPA-UHFFFAOYSA-N 0.000 description 1
• LLRLGOKYRRBEGE-UHFFFAOYSA-N 4-[4-(2,4-dichlorophenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1)=CC=C1OC1=CC=C(Cl)C=C1Cl LLRLGOKYRRBEGE-UHFFFAOYSA-N 0.000 description 1
• PWWRDVISZORIGY-UHFFFAOYSA-N 4-[4-(2,5-dimethylphenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1)=CC=C1OC1=CC(C)=CC=C1C PWWRDVISZORIGY-UHFFFAOYSA-N 0.000 description 1
• PYBBOFCEIUGTFC-UHFFFAOYSA-N 4-[4-(2,6-dimethylphenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1)=CC=C1OC1=C(C)C=CC=C1C PYBBOFCEIUGTFC-UHFFFAOYSA-N 0.000 description 1
• YGXKHVQVHCHPMB-UHFFFAOYSA-N 4-[4-(2-ethylphenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CCC1=CC=CC=C1OC1=CC=C(N2C(NN=C2C)=O)C=C1 YGXKHVQVHCHPMB-UHFFFAOYSA-N 0.000 description 1
• HNFWLUZIWLJEDP-UHFFFAOYSA-N 4-[4-(2-fluoro-6-methylphenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1)=CC=C1OC1=C(C)C=CC=C1F HNFWLUZIWLJEDP-UHFFFAOYSA-N 0.000 description 1
• VCBGOWIRWGFAOF-UHFFFAOYSA-N 4-[4-(3,4-dichlorophenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1)=CC=C1OC1=CC=C(Cl)C(Cl)=C1 VCBGOWIRWGFAOF-UHFFFAOYSA-N 0.000 description 1
• PBTGLAKUUZQCOX-UHFFFAOYSA-N 4-[4-(3,4-dimethylphenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1)=CC=C1OC1=CC=C(C)C(C)=C1 PBTGLAKUUZQCOX-UHFFFAOYSA-N 0.000 description 1
• UTVLNIMGADRABB-UHFFFAOYSA-N 4-[4-(3,5-dimethylphenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1)=CC=C1OC1=CC(C)=CC(C)=C1 UTVLNIMGADRABB-UHFFFAOYSA-N 0.000 description 1
• CKZORRHTHFTCKD-UHFFFAOYSA-N 4-[4-(3-chloro-2-fluorophenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1)=CC=C1OC1=CC=CC(Cl)=C1F CKZORRHTHFTCKD-UHFFFAOYSA-N 0.000 description 1
• ZWFGBNNTZMTMMJ-UHFFFAOYSA-N 4-[4-(3-chloro-4-fluorophenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1)=CC=C1OC1=CC=C(F)C(Cl)=C1 ZWFGBNNTZMTMMJ-UHFFFAOYSA-N 0.000 description 1
• GBVDDWYCRSVWRY-UHFFFAOYSA-N 4-[4-(3-chloro-5-fluorophenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1)=CC=C1OC1=CC(F)=CC(Cl)=C1 GBVDDWYCRSVWRY-UHFFFAOYSA-N 0.000 description 1
• MPCUATIVLODBLJ-UHFFFAOYSA-N 4-[4-(3-chloro-5-methoxyphenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound COC1=CC(Cl)=CC(OC=2C=CC(=CC=2)N2C(NN=C2C)=O)=C1 MPCUATIVLODBLJ-UHFFFAOYSA-N 0.000 description 1
• NAXHDKVFQMWPNI-UHFFFAOYSA-N 4-[4-(3-chlorophenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1)=CC=C1OC1=CC=CC(Cl)=C1 NAXHDKVFQMWPNI-UHFFFAOYSA-N 0.000 description 1
• IFWWFBSJDUPWOE-UHFFFAOYSA-N 4-[4-(3-ethoxyphenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CCOC1=CC=CC(OC=2C=CC(=CC=2)N2C(NN=C2C)=O)=C1 IFWWFBSJDUPWOE-UHFFFAOYSA-N 0.000 description 1
• MMYODIGMCPBBNL-UHFFFAOYSA-N 4-[4-(3-ethylphenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CCC1=CC=CC(OC=2C=CC(=CC=2)N2C(NN=C2C)=O)=C1 MMYODIGMCPBBNL-UHFFFAOYSA-N 0.000 description 1
• XSONJSCKMNUHGV-UHFFFAOYSA-N 4-[4-(3-methoxy-2-methylphenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound COC1=CC=CC(OC=2C=CC(=CC=2)N2C(NN=C2C)=O)=C1C XSONJSCKMNUHGV-UHFFFAOYSA-N 0.000 description 1
• FQCSOVIZRJNGQV-UHFFFAOYSA-N 4-[4-(3-methoxy-4-methylphenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound C1=C(C)C(OC)=CC(OC=2C=CC(=CC=2)N2C(NN=C2C)=O)=C1 FQCSOVIZRJNGQV-UHFFFAOYSA-N 0.000 description 1
• QRIPGYGUKLYSAX-UHFFFAOYSA-N 4-[4-(3-methoxyphenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound COC1=CC=CC(OC=2C=CC(=CC=2)N2C(NN=C2C)=O)=C1 QRIPGYGUKLYSAX-UHFFFAOYSA-N 0.000 description 1
• NBGXVOXMPPZUHR-UHFFFAOYSA-N 4-[4-(3-methylphenoxy)phenyl]-1H-1,2,4-triazol-5-one Chemical compound Cc1cccc(Oc2ccc(cc2)-n2cn[nH]c2=O)c1 NBGXVOXMPPZUHR-UHFFFAOYSA-N 0.000 description 1
• WLIFCBVXFGAXGE-UHFFFAOYSA-N 4-[4-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)phenoxy]-2-ethoxybenzonitrile Chemical compound C1=C(C#N)C(OCC)=CC(OC=2C=CC(=CC=2)N2C(C(C)(C)NC2=O)=O)=C1 WLIFCBVXFGAXGE-UHFFFAOYSA-N 0.000 description 1
• PHHFRGHBRKBAKY-UHFFFAOYSA-N 4-[4-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)phenoxy]-2-methoxybenzonitrile Chemical compound C1=C(C#N)C(OC)=CC(OC=2C=CC(=CC=2)N2C(C(C)(C)NC2=O)=O)=C1 PHHFRGHBRKBAKY-UHFFFAOYSA-N 0.000 description 1
• QQEXZRDXMWHNMD-UHFFFAOYSA-N 4-[4-(4-chloro-3-methoxyphenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound C1=C(Cl)C(OC)=CC(OC=2C=CC(=CC=2)N2C(NN=C2C)=O)=C1 QQEXZRDXMWHNMD-UHFFFAOYSA-N 0.000 description 1
• GVUUMTPBEYAKJM-UHFFFAOYSA-N 4-[4-(4-fluoro-3-methoxyphenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound C1=C(F)C(OC)=CC(OC=2C=CC(=CC=2)N2C(NN=C2C)=O)=C1 GVUUMTPBEYAKJM-UHFFFAOYSA-N 0.000 description 1
• OFEZEJXVRWEDRO-UHFFFAOYSA-N 4-[4-(5-methoxy-2-methylphenoxy)phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound COC1=CC=C(C)C(OC=2C=CC(=CC=2)N2C(NN=C2C)=O)=C1 OFEZEJXVRWEDRO-UHFFFAOYSA-N 0.000 description 1
• PZOSUSIPDSUKKS-MRXNPFEDSA-N 4-[4-[(4r)-4-ethyl-2,5-dioxoimidazolidin-1-yl]phenoxy]-2-methoxybenzonitrile Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=C1)=CC=C1OC1=CC=C(C#N)C(OC)=C1 PZOSUSIPDSUKKS-MRXNPFEDSA-N 0.000 description 1
• CXOVLXHTGLQPCU-UHFFFAOYSA-N 4-[4-[3-(dimethylamino)phenoxy]phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CN(C)C1=CC=CC(OC=2C=CC(=CC=2)N2C(NN=C2C)=O)=C1 CXOVLXHTGLQPCU-UHFFFAOYSA-N 0.000 description 1
• PNAKZBIOKBEYPQ-UHFFFAOYSA-N 4-[4-[4-fluoro-3-(trifluoromethoxy)phenoxy]phenyl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1)=CC=C1OC1=CC=C(F)C(OC(F)(F)F)=C1 PNAKZBIOKBEYPQ-UHFFFAOYSA-N 0.000 description 1
• ANICYERZZAFUOC-UHFFFAOYSA-N 4-[5-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)pyridin-2-yl]oxy-2-(trifluoromethoxy)benzonitrile Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C(OC(F)(F)F)=C1 ANICYERZZAFUOC-UHFFFAOYSA-N 0.000 description 1
• SCNZQQOTOHGJCN-UHFFFAOYSA-N 4-[5-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)pyridin-2-yl]oxy-2-ethoxybenzonitrile Chemical compound C1=C(C#N)C(OCC)=CC(OC=2N=CC(=CC=2)N2C(C(C)(C)NC2=O)=O)=C1 SCNZQQOTOHGJCN-UHFFFAOYSA-N 0.000 description 1
• DTQYJSBEDXCYPY-UHFFFAOYSA-N 4-[5-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)pyridin-2-yl]oxy-2-ethylbenzonitrile Chemical compound C1=C(C#N)C(CC)=CC(OC=2N=CC(=CC=2)N2C(C(C)(C)NC2=O)=O)=C1 DTQYJSBEDXCYPY-UHFFFAOYSA-N 0.000 description 1
• AGHZEKIJFOMEIB-UHFFFAOYSA-N 4-[5-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)pyridin-2-yl]oxy-2-methoxybenzonitrile Chemical compound C1=C(C#N)C(OC)=CC(OC=2N=CC(=CC=2)N2C(C(C)(C)NC2=O)=O)=C1 AGHZEKIJFOMEIB-UHFFFAOYSA-N 0.000 description 1
• NGZQBJVNNWBFSH-UHFFFAOYSA-N 4-[5-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)pyridin-2-yl]oxy-2-propan-2-ylbenzonitrile Chemical compound C1=C(C#N)C(C(C)C)=CC(OC=2N=CC(=CC=2)N2C(C(C)(C)NC2=O)=O)=C1 NGZQBJVNNWBFSH-UHFFFAOYSA-N 0.000 description 1
• IGOVPXNEHNQYNI-UHFFFAOYSA-N 4-[5-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)pyridin-2-yl]oxy-2-propan-2-yloxybenzonitrile Chemical compound C1=C(C#N)C(OC(C)C)=CC(OC=2N=CC(=CC=2)N2C(C(C)(C)NC2=O)=O)=C1 IGOVPXNEHNQYNI-UHFFFAOYSA-N 0.000 description 1
• UXAHHXXMSQCKRN-UHFFFAOYSA-N 4-[5-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)pyridin-2-yl]oxy-3-(trifluoromethyl)benzonitrile Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C=C1C(F)(F)F UXAHHXXMSQCKRN-UHFFFAOYSA-N 0.000 description 1
• DDURMVVZNDJGQP-UHFFFAOYSA-N 4-[5-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)pyridin-2-yl]oxy-3-ethylbenzonitrile Chemical compound CCC1=CC(C#N)=CC=C1OC1=CC=C(N2C(C(C)(C)NC2=O)=O)C=N1 DDURMVVZNDJGQP-UHFFFAOYSA-N 0.000 description 1
• RDOJVSRQASEHPG-UHFFFAOYSA-N 4-[5-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)pyridin-2-yl]oxy-3-methylbenzonitrile Chemical compound CC1=CC(C#N)=CC=C1OC1=CC=C(N2C(C(C)(C)NC2=O)=O)C=N1 RDOJVSRQASEHPG-UHFFFAOYSA-N 0.000 description 1
• MYOYKPGYUWLSEY-UHFFFAOYSA-N 4-[5-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)pyrimidin-2-yl]oxy-2-ethylbenzonitrile Chemical compound C1=C(C#N)C(CC)=CC(OC=2N=CC(=CN=2)N2C(C(C)(C)NC2=O)=O)=C1 MYOYKPGYUWLSEY-UHFFFAOYSA-N 0.000 description 1
• SZFAQEZAWQEIEM-CYBMUJFWSA-N 4-[5-[(4r)-4-ethyl-2,5-dioxoimidazolidin-1-yl]pyridin-2-yl]oxy-2-(trifluoromethoxy)benzonitrile Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C(OC(F)(F)F)=C1 SZFAQEZAWQEIEM-CYBMUJFWSA-N 0.000 description 1
• GMTUEPZZDXKGJA-CQSZACIVSA-N 4-[5-[(4r)-4-ethyl-2,5-dioxoimidazolidin-1-yl]pyridin-2-yl]oxy-2-methoxybenzonitrile Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C(OC)=C1 GMTUEPZZDXKGJA-CQSZACIVSA-N 0.000 description 1
• SWDQPUHZXXVHMN-MRXNPFEDSA-N 4-[5-[(4r)-4-ethyl-2,5-dioxoimidazolidin-1-yl]pyridin-2-yl]oxy-2-propan-2-yloxybenzonitrile Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C(OC(C)C)=C1 SWDQPUHZXXVHMN-MRXNPFEDSA-N 0.000 description 1
• XGZOSQSLPNVOTE-CQSZACIVSA-N 4-[5-[(4r)-4-ethyl-2,5-dioxoimidazolidin-1-yl]pyridin-2-yl]oxy-3-methylbenzonitrile Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C=C1C XGZOSQSLPNVOTE-CQSZACIVSA-N 0.000 description 1
• XNHVHUBNLMEZFO-CYBMUJFWSA-N 4-[5-[(4r)-4-ethyl-2,5-dioxoimidazolidin-1-yl]pyrimidin-2-yl]oxy-3-methylbenzonitrile Chemical compound O=C1[C@@H](CC)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(C#N)C=C1C XNHVHUBNLMEZFO-CYBMUJFWSA-N 0.000 description 1
• BMGFTHHZPRDEAB-GOSISDBHSA-N 4-[5-[(4r)-4-ethyl-4-methyl-2,5-dioxoimidazolidin-1-yl]pyridin-2-yl]oxy-2-(trifluoromethoxy)benzonitrile Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C(OC(F)(F)F)=C1 BMGFTHHZPRDEAB-GOSISDBHSA-N 0.000 description 1
• KOOQIOPWRYGXJW-OAQYLSRUSA-N 4-[5-[(4r)-4-ethyl-4-methyl-2,5-dioxoimidazolidin-1-yl]pyridin-2-yl]oxy-2-propan-2-ylbenzonitrile Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C(C(C)C)=C1 KOOQIOPWRYGXJW-OAQYLSRUSA-N 0.000 description 1
• DPKPVAXHVRFOCP-OAQYLSRUSA-N 4-[5-[(4r)-4-ethyl-4-methyl-2,5-dioxoimidazolidin-1-yl]pyridin-2-yl]oxy-2-propan-2-yloxybenzonitrile Chemical compound O=C1[C@](CC)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(C#N)C(OC(C)C)=C1 DPKPVAXHVRFOCP-OAQYLSRUSA-N 0.000 description 1
• KAFDWVNRZRPCEJ-UHFFFAOYSA-N 4-[6-(2,3-dimethylphenoxy)pyridin-3-yl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=N1)=CC=C1OC1=CC=CC(C)=C1C KAFDWVNRZRPCEJ-UHFFFAOYSA-N 0.000 description 1
• NUTDLFJSTOHFNY-UHFFFAOYSA-N 4-[6-(3-ethoxyphenoxy)-5-methylpyridin-3-yl]-3-methyl-1H-1,2,4-triazol-5-one Chemical compound CCOc1cccc(Oc2ncc(cc2C)-n2c(C)n[nH]c2=O)c1 NUTDLFJSTOHFNY-UHFFFAOYSA-N 0.000 description 1
• JPYJRVVTGDSUAV-UHFFFAOYSA-N 4-[6-(3-propan-2-ylphenoxy)pyridin-3-yl]-1H-1,2,4-triazol-5-one Chemical compound CC(C)c1cccc(Oc2ccc(cn2)-n2cn[nH]c2=O)c1 JPYJRVVTGDSUAV-UHFFFAOYSA-N 0.000 description 1
• GADKJUHCHUWHKA-UHFFFAOYSA-N 4-[6-[(3,3-diethyl-1h-2-benzofuran-5-yl)oxy]pyridin-3-yl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound C1=C2C(CC)(CC)OCC2=CC=C1OC(N=C1)=CC=C1N1C(C)=NNC1=O GADKJUHCHUWHKA-UHFFFAOYSA-N 0.000 description 1
• IRMDVYGLPAWMSG-UHFFFAOYSA-N 4-[6-[(3,3-dimethyl-2h-1-benzofuran-4-yl)oxy]-5-methylpyridin-3-yl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=C1C)=CN=C1OC1=CC=CC2=C1C(C)(C)CO2 IRMDVYGLPAWMSG-UHFFFAOYSA-N 0.000 description 1
• FWBDVGGUCXZCAY-UHFFFAOYSA-N 4-[6-[(3,3-dimethyl-2h-1-benzofuran-4-yl)oxy]pyridin-3-yl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=N1)=CC=C1OC1=CC=CC2=C1C(C)(C)CO2 FWBDVGGUCXZCAY-UHFFFAOYSA-N 0.000 description 1
• RZHPRAFVXFPVPT-UHFFFAOYSA-N 4-[6-[(3-tert-butyl-1,3-dihydro-2-benzofuran-4-yl)oxy]pyridin-3-yl]-3-methyl-1h-1,2,4-triazol-5-one Chemical compound CC1=NNC(=O)N1C(C=N1)=CC=C1OC1=CC=CC2=C1C(C(C)(C)C)OC2 RZHPRAFVXFPVPT-UHFFFAOYSA-N 0.000 description 1
• QISOBCMNUJQOJU-UHFFFAOYSA-N 4-bromo-1h-pyrazole-5-carboxylic acid Chemical compound OC(=O)C=1NN=CC=1Br QISOBCMNUJQOJU-UHFFFAOYSA-N 0.000 description 1
• YFHJRRXHMHBQPT-UHFFFAOYSA-N 5,5-dimethyl-3-(2-spiro[1h-2-benzofuran-3,1'-cyclobutane]-5-yloxypyrimidin-5-yl)imidazolidine-2,4-dione Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(COC23CCC3)C2=C1 YFHJRRXHMHBQPT-UHFFFAOYSA-N 0.000 description 1
• XZCMOAFWCRQHLN-UHFFFAOYSA-N 5,5-dimethyl-3-(2-spiro[1h-2-benzofuran-3,1'-cyclopentane]-5-yloxypyrimidin-5-yl)imidazolidine-2,4-dione Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CN=C1OC1=CC=C(COC23CCCC3)C2=C1 XZCMOAFWCRQHLN-UHFFFAOYSA-N 0.000 description 1
• FGWRIDDFGDQKEH-UHFFFAOYSA-N 5,5-dimethyl-3-(6-spiro[1,3-dihydroisochromene-4,1'-cyclopropane]-5-yloxypyridin-3-yl)imidazolidine-2,4-dione Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=CC2=C1C1(CC1)COC2 FGWRIDDFGDQKEH-UHFFFAOYSA-N 0.000 description 1
• XLLYTTJDCNRJGT-UHFFFAOYSA-N 5,5-dimethyl-3-(6-spiro[1h-2-benzofuran-3,1'-cyclopentane]-5-yloxypyridin-3-yl)imidazolidine-2,4-dione Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=C(COC23CCCC3)C2=C1 XLLYTTJDCNRJGT-UHFFFAOYSA-N 0.000 description 1
• BUQRXVHOLHZBJQ-UHFFFAOYSA-N 5,5-dimethyl-3-(6-spiro[2h-1-benzofuran-3,1'-cyclopropane]-4-yloxypyridin-3-yl)imidazolidine-2,4-dione Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=CC2=C1C1(CC1)CO2 BUQRXVHOLHZBJQ-UHFFFAOYSA-N 0.000 description 1
• RZIJNHNNRDJJHT-UHFFFAOYSA-N 5,5-dimethyl-3-[2-(7-methylspiro[1h-2-benzofuran-3,1'-cyclobutane]-4-yl)oxypyrimidin-5-yl]imidazolidine-2,4-dione Chemical compound C1OC2(CCC2)C2=C1C(C)=CC=C2OC(N=C1)=NC=C1N1C(=O)NC(C)(C)C1=O RZIJNHNNRDJJHT-UHFFFAOYSA-N 0.000 description 1
• JBUBKHPJMWXPDR-UHFFFAOYSA-N 5,5-dimethyl-3-[4-[(3-methyl-1,2-benzoxazol-4-yl)oxy]phenyl]imidazolidine-2,4-dione Chemical compound C=12C(C)=NOC2=CC=CC=1OC(C=C1)=CC=C1N1C(=O)NC(C)(C)C1=O JBUBKHPJMWXPDR-UHFFFAOYSA-N 0.000 description 1
• YNOKCEJLADNIGC-UHFFFAOYSA-N 5,5-dimethyl-3-[6-[3-(trifluoromethoxy)phenoxy]pyridin-3-yl]imidazolidine-2,4-dione Chemical compound O=C1C(C)(C)NC(=O)N1C(C=N1)=CC=C1OC1=CC=CC(OC(F)(F)F)=C1 YNOKCEJLADNIGC-UHFFFAOYSA-N 0.000 description 1
• PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 1
• FUTZCNTWTBPWAV-UHFFFAOYSA-N 6-[6-(3-methoxy-4-methylphenoxy)pyridin-3-yl]-4,6-diazaspiro[2.4]heptane-5,7-dione Chemical compound C1=C(C)C(OC)=CC(OC=2N=CC(=CC=2)N2C(C3(CC3)NC2=O)=O)=C1 FUTZCNTWTBPWAV-UHFFFAOYSA-N 0.000 description 1
• ZJEURBVUUVBUMC-UHFFFAOYSA-N 6-[6-[(3,3-dimethyl-2h-1-benzofuran-4-yl)oxy]pyridin-3-yl]-4,6-diazaspiro[2.4]heptane-5,7-dione Chemical compound C=12C(C)(C)COC2=CC=CC=1OC(N=C1)=CC=C1N(C1=O)C(=O)NC21CC2 ZJEURBVUUVBUMC-UHFFFAOYSA-N 0.000 description 1
• MCZVVEAVQUTBQO-UHFFFAOYSA-N 7-[6-(3-methoxy-4-methylphenoxy)pyridin-3-yl]-5,7-diazaspiro[3.4]octane-6,8-dione Chemical compound C1=C(C)C(OC)=CC(OC=2N=CC(=CC=2)N2C(C3(CCC3)NC2=O)=O)=C1 MCZVVEAVQUTBQO-UHFFFAOYSA-N 0.000 description 1
• GOPBAXGLRUCBSV-UHFFFAOYSA-N 7-[6-[(3,3-dimethyl-2h-1-benzofuran-4-yl)oxy]pyridin-3-yl]-5,7-diazaspiro[3.4]octane-6,8-dione Chemical compound C=12C(C)(C)COC2=CC=CC=1OC(N=C1)=CC=C1N(C1=O)C(=O)NC21CCC2 GOPBAXGLRUCBSV-UHFFFAOYSA-N 0.000 description 1
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
• RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
• 241000242759 Actiniaria Species 0.000 description 1
• ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 241001083548 Anemone Species 0.000 description 1
• 241000242762 Anemonia sulcata Species 0.000 description 1
• 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
• 206010003011 Appendicitis Diseases 0.000 description 1
• 208000006820 Arthralgia Diseases 0.000 description 1
• BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
• 241000416162 Astragalus gummifer Species 0.000 description 1
• 208000008035 Back Pain Diseases 0.000 description 1
• COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• OKTJSMMVPCPJKN-NJFSPNSNSA-N Carbon-14 Chemical compound [14C] OKTJSMMVPCPJKN-NJFSPNSNSA-N 0.000 description 1
• 102000019034 Chemokines Human genes 0.000 description 1
• 108010012236 Chemokines Proteins 0.000 description 1
• KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
• ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
• 241001638933 Cochlicella barbara Species 0.000 description 1
• 241000699802 Cricetulus griseus Species 0.000 description 1
• 102000004127 Cytokines Human genes 0.000 description 1
• 108090000695 Cytokines Proteins 0.000 description 1
• YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
• 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
• 239000004150 EU approved colour Substances 0.000 description 1
• PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 208000007514 Herpes zoster Diseases 0.000 description 1
• 101001049849 Homo sapiens Calcium-activated potassium channel subunit beta-1 Proteins 0.000 description 1
• 101100180613 Homo sapiens KCNMA1 gene Proteins 0.000 description 1
• 101000635799 Homo sapiens Run domain Beclin-1-interacting and cysteine-rich domain-containing protein Proteins 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
• HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
• 108090000193 Interleukin-1 beta Proteins 0.000 description 1
• 102000003777 Interleukin-1 beta Human genes 0.000 description 1
• 102000004125 Interleukin-1alpha Human genes 0.000 description 1
• 108010082786 Interleukin-1alpha Proteins 0.000 description 1
• 102000004889 Interleukin-6 Human genes 0.000 description 1
• 108090001005 Interleukin-6 Proteins 0.000 description 1
• PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
• 239000007836 KH2PO4 Substances 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
• 240000007472 Leucaena leucocephala Species 0.000 description 1
• 239000005089 Luciferase Substances 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 208000019695 Migraine disease Diseases 0.000 description 1
• 206010027940 Mood altered Diseases 0.000 description 1
• 241000699666 Mus <mouse, genus> Species 0.000 description 1
• 208000000112 Myalgia Diseases 0.000 description 1
• CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
• GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
• BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
• BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 description 1
• 208000000114 Pain Threshold Diseases 0.000 description 1
• 235000019483 Peanut oil Nutrition 0.000 description 1
• 208000004983 Phantom Limb Diseases 0.000 description 1
• 206010036376 Postherpetic Neuralgia Diseases 0.000 description 1
• 102100030852 Run domain Beclin-1-interacting and cysteine-rich domain-containing protein Human genes 0.000 description 1
• 206010070834 Sensitisation Diseases 0.000 description 1
• 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
• 108010052164 Sodium Channels Proteins 0.000 description 1
• 102000018674 Sodium Channels Human genes 0.000 description 1
• 102000005157 Somatostatin Human genes 0.000 description 1
• 108010056088 Somatostatin Proteins 0.000 description 1
• 208000010040 Sprains and Strains Diseases 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
• FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical compound [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
• 208000000491 Tendinopathy Diseases 0.000 description 1
• 206010043255 Tendonitis Diseases 0.000 description 1
• 229920001615 Tragacanth Polymers 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
• 241000269370 Xenopus <genus> Species 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 229960001138 acetylsalicylic acid Drugs 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 108700032993 adenovirus CELO Proteins 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 238000012387 aerosolization Methods 0.000 description 1
• 239000000556 agonist Substances 0.000 description 1
• 230000007815 allergy Effects 0.000 description 1
• 206010053552 allodynia Diseases 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• 230000001668 ameliorated effect Effects 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 229940024606 amino acid Drugs 0.000 description 1
• 150000001413 amino acids Chemical class 0.000 description 1
• 239000003708 ampul Substances 0.000 description 1
• 230000000202 analgesic effect Effects 0.000 description 1
• 229940035676 analgesics Drugs 0.000 description 1
• 238000000540 analysis of variance Methods 0.000 description 1
• 239000000730 antalgic agent Substances 0.000 description 1
• 239000000074 antisense oligonucleotide Substances 0.000 description 1
• 238000012230 antisense oligonucleotides Methods 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• 239000008365 aqueous carrier Substances 0.000 description 1
• 229940009098 aspartate Drugs 0.000 description 1
• 238000011914 asymmetric synthesis Methods 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• 210000000467 autonomic pathway Anatomy 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
• 230000002902 bimodal effect Effects 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 230000015572 biosynthetic process Effects 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 239000005388 borosilicate glass Substances 0.000 description 1
• 229910052794 bromium Inorganic materials 0.000 description 1
• 210000004899 c-terminal region Anatomy 0.000 description 1
• 239000001110 calcium chloride Substances 0.000 description 1
• 229910001628 calcium chloride Inorganic materials 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 229960002504 capsaicin Drugs 0.000 description 1
• 235000017663 capsaicin Nutrition 0.000 description 1
• 229960000623 carbamazepine Drugs 0.000 description 1
• FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
• 150000001721 carbon Chemical group 0.000 description 1
• 229910002091 carbon monoxide Inorganic materials 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
• 208000022371 chronic pain syndrome Diseases 0.000 description 1
• 230000007012 clinical effect Effects 0.000 description 1
• 229940110456 cocoa butter Drugs 0.000 description 1
• 235000019868 cocoa butter Nutrition 0.000 description 1
• OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Natural products C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 1
• 229960004126 codeine Drugs 0.000 description 1
• 230000002508 compound effect Effects 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 230000001054 cortical effect Effects 0.000 description 1
• 210000004748 cultured cell Anatomy 0.000 description 1
• 125000006165 cyclic alkyl group Chemical group 0.000 description 1
• 238000013480 data collection Methods 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 239000008367 deionised water Substances 0.000 description 1
• 229910021641 deionized water Inorganic materials 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• 230000002999 depolarising effect Effects 0.000 description 1
• 229910052805 deuterium Inorganic materials 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 description 1
• 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
• 238000007865 diluting Methods 0.000 description 1
• ASQQEOXYFGEFKQ-UHFFFAOYSA-N dioxirane Chemical compound C1OO1 ASQQEOXYFGEFKQ-UHFFFAOYSA-N 0.000 description 1
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
• 238000009509 drug development Methods 0.000 description 1
• 239000003596 drug target Substances 0.000 description 1
• 229960002866 duloxetine Drugs 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 238000005538 encapsulation Methods 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 239000003797 essential amino acid Substances 0.000 description 1
• 235000020776 essential amino acid Nutrition 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 229960002428 fentanyl Drugs 0.000 description 1
• PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
• 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 description 1
• 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
• 238000011010 flushing procedure Methods 0.000 description 1
• 150000004675 formic acid derivatives Chemical class 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 210000004317 gizzard Anatomy 0.000 description 1
• 229940050410 gluconate Drugs 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 230000005484 gravity Effects 0.000 description 1
• 230000005802 health problem Effects 0.000 description 1
• 229910001385 heavy metal Inorganic materials 0.000 description 1
• 230000000971 hippocampal effect Effects 0.000 description 1
• 210000003630 histaminocyte Anatomy 0.000 description 1
• 150000004677 hydrates Chemical class 0.000 description 1
• OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
• 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
• 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
• 230000002102 hyperpolarization Effects 0.000 description 1
• 229960001680 ibuprofen Drugs 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 206010022437 insomnia Diseases 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 230000009545 invasion Effects 0.000 description 1
• PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical group II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
• 229910052740 iodine Inorganic materials 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 229960002725 isoflurane Drugs 0.000 description 1
• 210000001503 joint Anatomy 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 235000010445 lecithin Nutrition 0.000 description 1
• 239000000787 lecithin Substances 0.000 description 1
• 229940067606 lecithin Drugs 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 239000003589 local anesthetic agent Substances 0.000 description 1
• 229960005015 local anesthetics Drugs 0.000 description 1
• 230000033001 locomotion Effects 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 230000017813 membrane repolarization Effects 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 239000002207 metabolite Substances 0.000 description 1
• 206010027599 migraine Diseases 0.000 description 1
• 150000007522 mineralic acids Chemical class 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
• 230000036651 mood Effects 0.000 description 1
• 230000007510 mood change Effects 0.000 description 1
• 229960005181 morphine Drugs 0.000 description 1
• 230000037023 motor activity Effects 0.000 description 1
• 201000006417 multiple sclerosis Diseases 0.000 description 1
• 208000013465 muscle pain Diseases 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
• 229960002009 naproxen Drugs 0.000 description 1
• CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
• 229910017604 nitric acid Inorganic materials 0.000 description 1
• 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
• 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 1
• 231100000862 numbness Toxicity 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 238000001543 one-way ANOVA Methods 0.000 description 1
• 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 150000007524 organic acids Chemical class 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 201000008482 osteoarthritis Diseases 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 150000003891 oxalate salts Chemical class 0.000 description 1
• 229960002085 oxycodone Drugs 0.000 description 1
• 239000001301 oxygen Chemical group 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• 230000008052 pain pathway Effects 0.000 description 1
• 230000037040 pain threshold Effects 0.000 description 1
• 238000007427 paired t-test Methods 0.000 description 1
• 229960005489 paracetamol Drugs 0.000 description 1
• 229960004662 parecoxib Drugs 0.000 description 1
• TZRHLKRLEZJVIJ-UHFFFAOYSA-N parecoxib Chemical compound C1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C1=C(C)ON=C1C1=CC=CC=C1 TZRHLKRLEZJVIJ-UHFFFAOYSA-N 0.000 description 1
• 239000000312 peanut oil Substances 0.000 description 1
• 210000005223 peripheral sensory neuron Anatomy 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 230000008288 physiological mechanism Effects 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 229920001983 poloxamer Polymers 0.000 description 1
• 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
• 229920000053 polysorbate 80 Polymers 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 230000002980 postoperative effect Effects 0.000 description 1
• GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 239000000047 product Substances 0.000 description 1
• 230000000770 proinflammatory effect Effects 0.000 description 1
• 239000003642 reactive oxygen metabolite Substances 0.000 description 1
• 239000000018 receptor agonist Substances 0.000 description 1
• 229940044601 receptor agonist Drugs 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000026416 response to pain Effects 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• 239000000523 sample Substances 0.000 description 1
• 230000035807 sensation Effects 0.000 description 1
• 230000008313 sensitization Effects 0.000 description 1
• 230000031893 sensory processing Effects 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 210000002027 skeletal muscle Anatomy 0.000 description 1
• 210000002460 smooth muscle Anatomy 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 239000003195 sodium channel blocking agent Substances 0.000 description 1
• 230000003238 somatosensory effect Effects 0.000 description 1
• NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
• 229960000553 somatostatin Drugs 0.000 description 1
• 230000002269 spontaneous effect Effects 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 230000000707 stereoselective effect Effects 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• GGCSSNBKKAUURC-UHFFFAOYSA-N sufentanil Chemical compound C1CN(CCC=2SC=CC=2)CCC1(COC)N(C(=O)CC)C1=CC=CC=C1 GGCSSNBKKAUURC-UHFFFAOYSA-N 0.000 description 1
• 229960004739 sufentanil Drugs 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 229910052717 sulfur Inorganic materials 0.000 description 1
• 125000004434 sulfur atom Chemical group 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 239000002511 suppository base Substances 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 239000003894 surgical glue Substances 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 230000008961 swelling Effects 0.000 description 1
• 230000002889 sympathetic effect Effects 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 238000010189 synthetic method Methods 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 201000004415 tendinitis Diseases 0.000 description 1
• 210000002435 tendon Anatomy 0.000 description 1
• 210000001103 thalamus Anatomy 0.000 description 1
• 230000000451 tissue damage Effects 0.000 description 1
• 231100000827 tissue damage Toxicity 0.000 description 1
• 238000003354 tissue distribution assay Methods 0.000 description 1
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
• 235000010487 tragacanth Nutrition 0.000 description 1
• 239000000196 tragacanth Substances 0.000 description 1
• 229940116362 tragacanth Drugs 0.000 description 1
• 229960004380 tramadol Drugs 0.000 description 1
• TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 description 1
• 238000001890 transfection Methods 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
• 229910052721 tungsten Inorganic materials 0.000 description 1
• 210000003556 vascular endothelial cell Anatomy 0.000 description 1
• 230000002227 vasoactive effect Effects 0.000 description 1
• 210000001835 viscera Anatomy 0.000 description 1
• 208000009935 visceral pain Diseases 0.000 description 1